CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | tetralins |
|
Accession: | CHEBI:36786
|
browse the term
|
Definition: | Compounds containing a tetralin skeleton. |
Synonyms: | related_synonym: | 1,2,3,4-tetrahydronaphthalenes |
|
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions |
ISO |
5-methoxy-1-methyl-2-(n-propylamino)tetralin binds to and results in decreased activity of DRD2 protein |
CTD |
PMID:10728880 |
|
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Drd3 |
dopamine receptor D3 |
multiple interactions |
ISO |
5-methoxy-1-methyl-2-(n-propylamino)tetralin binds to and results in decreased activity of DRD3 protein |
CTD |
PMID:10728880 |
|
NCBI chr11:61,819,102...61,883,223
Ensembl chr11:61,822,077...61,874,327
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions |
ISO |
Am 580 promotes the reaction [Tretinoin results in increased expression of ABCG2 mRNA] |
CTD |
PMID:20562004 |
|
NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621
|
|
G |
Ada |
adenosine deaminase |
increases expression |
ISO |
Am 580 results in increased expression of ADA mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Agpat4 |
1-acylglycerol-3-phosphate O-acyltransferase 4 |
increases expression |
ISO |
Am 580 results in increased expression of AGPAT4 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:48,716,094...48,826,292
Ensembl chr 1:48,719,633...48,825,364
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Am 580 results in decreased expression of AGRN mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:173,589,910...173,622,813
Ensembl chr 5:173,589,819...173,622,645
|
|
G |
Ajap1 |
adherens junctions associated protein 1 |
increases expression |
ISO |
Am 580 results in increased expression of AJAP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:170,615,885...170,679,315
Ensembl chr 5:170,615,886...170,679,315
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
increases expression |
ISO |
Am 580 results in increased expression of APLP2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:32,298,526...32,328,821
Ensembl chr 8:32,298,532...32,328,839
|
|
G |
Ar |
androgen receptor |
decreases activity |
ISO |
Am 580 results in decreased activity of AR protein |
CTD |
PMID:25257666 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of ATP2B1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:41,114,606...41,223,138
Ensembl chr 7:41,114,697...41,220,579
|
|
G |
Bag2 |
BAG cochaperone 2 |
increases expression |
ISO |
Am 580 results in increased expression of BAG2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:38,456,487...38,467,120
Ensembl chr 9:38,456,468...38,467,118
|
|
G |
Calcrl |
calcitonin receptor like receptor |
decreases expression |
ISO |
Am 580 results in decreased expression of CALCRL mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 3:71,747,938...71,845,487
Ensembl chr 3:71,747,956...71,845,232
|
|
G |
Capn1 |
calpain 1 |
decreases expression decreases activity |
ISO |
Am 580 results in decreased expression of CAPN1 mRNA Am 580 results in decreased activity of CAPN1 protein |
CTD |
PMID:17460283 |
|
NCBI chr 1:221,346,081...221,370,965
Ensembl chr 1:221,346,066...221,370,322
|
|
G |
Capn2 |
calpain 2 |
decreases expression multiple interactions decreases activity |
ISO |
Am 580 results in decreased expression of CAPN2 mRNA Am 580 inhibits the reaction [Hydrogen Peroxide results in increased activity of CAPN2 protein]; Am 580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CAPN2 mRNA] Am 580 results in decreased activity of CAPN2 protein |
CTD |
PMID:17460283 |
|
NCBI chr13:100,878,649...100,928,811
Ensembl chr13:100,878,650...100,928,811
|
|
G |
Cd1d1 |
CD1d1 molecule |
increases expression multiple interactions |
ISO |
Am 580 results in increased expression of CD1D mRNA Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CD1D mRNA] |
CTD |
PMID:16982809 PMID:17392484 |
|
NCBI chr 2:186,330,298...186,333,805
Ensembl chr 2:186,330,298...186,333,805
|
|
G |
Cd300a |
Cd300a molecule |
increases expression |
ISO |
Am 580 results in increased expression of CD300A mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:103,437,978...103,451,170
Ensembl chr10:103,438,303...103,450,947
|
|
G |
Cd300lb |
CD300 molecule-like family member b |
increases expression |
ISO |
Am 580 results in increased expression of CD300LB mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:103,471,082...103,481,071
Ensembl chr10:103,467,725...103,481,153
|
|
G |
Cd300lf |
Cd300 molecule-like family member F |
increases expression |
ISO |
Am 580 results in increased expression of CD300LF mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:103,669,781...103,690,584
Ensembl chr10:103,670,028...103,687,425
|
|
G |
Cd38 |
CD38 molecule |
increases expression multiple interactions |
ISO |
Am 580 results in increased expression of CD38 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Am 580 results in increased expression of CD38 protein]; [Ro 25-6603 co-treated with Am 580] results in increased expression of CD38 protein |
CTD |
PMID:16329108 |
|
NCBI chr14:71,714,768...71,754,990
Ensembl chr14:71,715,269...71,754,672
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
affects localization |
ISO |
Am 580 affects the localization of CDKN1B protein |
CTD |
PMID:16618747 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cdr2l |
cerebellar degeneration-related protein 2-like |
decreases expression |
ISO |
Am 580 results in decreased expression of CDR2L mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:103,934,364...103,948,318
Ensembl chr10:103,934,797...103,948,322
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
increases expression |
ISO |
Am 580 results in increased expression of COL5A3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:21,786,324...21,831,751
Ensembl chr 8:21,786,324...21,831,668
|
|
G |
Cttnbp2 |
cortactin binding protein 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of CTTNBP2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:42,932,897...43,096,454
Ensembl chr 4:42,932,903...43,096,399
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases expression |
ISO |
Am 580 results in increased expression of CYP19A1 mRNA |
CTD |
PMID:15941851 |
|
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CYP26A1 mRNA] |
CTD |
PMID:10953040 |
|
NCBI chr 1:256,382,861...256,386,729
Ensembl chr 1:256,382,791...256,386,729
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
increases expression |
ISO |
Am 580 results in increased expression of DCSTAMP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:78,642,016...78,651,763
Ensembl chr 7:78,649,875...78,650,906
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
Am 580 results in increased expression of DHRS3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
|
|
G |
Dmpk |
DM1 protein kinase |
decreases expression |
ISO |
Am 580 results in decreased expression of DMPK mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:79,988,096...79,999,358
Ensembl chr 1:79,989,019...79,999,364
|
|
G |
Dmwd |
DM1 locus, WD repeat containing |
decreases expression |
ISO |
Am 580 results in decreased expression of DMWD mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:79,981,270...79,987,997
Ensembl chr 1:79,981,355...79,987,562
|
|
G |
Dnajc5b |
DnaJ heat shock protein family (Hsp40) member C5 beta |
increases expression |
ISO |
Am 580 results in increased expression of DNAJC5B mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:104,290,726...104,382,846
Ensembl chr 2:104,290,726...104,382,878
|
|
G |
Ets2 |
ETS proto-oncogene 2, transcription factor |
increases expression |
ISO |
Am 580 results in increased expression of ETS2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr11:36,075,709...36,092,495
Ensembl chr11:36,075,709...36,092,495
|
|
G |
Fam241a |
family with sequence similarity 241 member A |
decreases expression |
ISO |
Am 580 results in decreased expression of FAM241A mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:232,214,331...232,245,319
Ensembl chr 2:232,214,331...232,245,319
|
|
G |
Fas |
Fas cell surface death receptor |
increases activity |
ISO |
Am 580 results in increased activity of FAS protein |
CTD |
PMID:15703382 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
Am 580 results in increased expression of FN1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fut7 |
fucosyltransferase 7 |
decreases expression |
ISO |
Am 580 results in decreased expression of FUT7 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 3:2,637,281...2,646,497
Ensembl chr 3:2,642,531...2,646,648
|
|
G |
Galm |
galactose mutarotase |
increases expression |
ISO |
Am 580 results in increased expression of GALM mRNA |
CTD |
PMID:18052213 |
|
NCBI chr 6:2,808,988...2,860,742
Ensembl chr 6:2,808,841...2,860,744
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
Am 580 results in increased expression of GDF15 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr16:20,555,395...20,557,978
Ensembl chr16:20,555,395...20,557,978
|
|
G |
Gpd1l |
glycerol-3-phosphate dehydrogenase 1-like |
decreases expression |
ISO |
Am 580 results in decreased expression of GPD1L mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:122,957,570...122,987,236
Ensembl chr 8:122,954,948...122,987,191
|
|
G |
Gusb |
glucuronidase, beta |
increases expression |
ISO |
Am 580 results in increased expression of GUSB mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:30,202,066...30,215,583
Ensembl chr12:30,198,822...30,227,771
|
|
G |
Hipk2 |
homeodomain interacting protein kinase 2 |
increases expression |
ISO |
Am 580 results in increased expression of HIPK2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:66,438,390...66,625,183
Ensembl chr 4:66,445,266...66,624,912
|
|
G |
Hist1h2bd |
histone cluster 1 H2B family member D |
decreases expression |
ISO |
Am 580 results in decreased expression of H2BC5 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr17:44,833,924...44,834,305
Ensembl chr17:44,833,924...44,834,305
|
|
G |
Hlx |
H2.0-like homeobox |
decreases expression |
ISO |
Am 580 results in decreased expression of HLX mRNA |
CTD |
PMID:16982809 |
|
NCBI chr13:102,637,967...102,643,376
Ensembl chr13:102,637,769...102,643,223
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
multiple interactions increases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IFNGR1 protein] |
CTD |
PMID:16085646 |
|
NCBI chr 1:15,062,380...15,080,815
Ensembl chr 1:15,062,432...15,080,907
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of IL1R1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:46,962,291...47,038,139
Ensembl chr 9:46,962,288...47,036,670
|
|
G |
Il1rap |
interleukin 1 receptor accessory protein |
decreases expression |
ISO |
Am 580 results in decreased expression of IL1RAP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr11:77,456,648...77,593,208
Ensembl chr11:77,463,954...77,593,207
|
|
G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
increases expression |
ISO |
Am 580 results in increased expression of INPP5F mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:200,037,749...200,116,524
Ensembl chr 1:200,037,749...200,116,524
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of IPCEF1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:43,563,457...43,743,424
Ensembl chr 1:43,567,842...43,638,161
|
|
G |
Irf1 |
interferon regulatory factor 1 |
multiple interactions increases expression increases activity |
ISO |
Am 580 affects the localization of [Am 580 results in increased expression of IRF1 protein]; Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of IRF1 protein]; Tretinoin promotes the reaction [Am 580 results in increased activity of IRF1 protein] |
CTD |
PMID:16085646 PMID:16636311 |
|
NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
|
|
G |
Itgae |
integrin subunit alpha E |
increases expression |
ISO |
Am 580 results in increased expression of ITGAE mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:59,652,324...59,711,885
Ensembl chr10:59,539,405...59,711,874
|
|
G |
Kifc2 |
kinesin family member C2 |
decreases expression |
ISO |
Am 580 results in decreased expression of KIFC2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:117,722,732...117,730,702
Ensembl chr 7:117,723,263...117,730,702
|
|
G |
Lair1 |
leukocyte-associated immunoglobulin-like receptor 1 |
increases expression |
ISO |
Am 580 results in increased expression of LAIR1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:73,752,192...73,870,421
Ensembl chr 1:73,837,944...73,868,695
|
|
G |
Lelp1 |
late cornified envelope-like proline-rich 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of LELP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:192,035,927...192,037,885
|
|
G |
LOC100302372 |
hypothetical protein LOC100302372 |
decreases expression |
ISO |
Am 580 results in decreased expression of KIAA0040 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr13:77,784,516...77,822,333
Ensembl chr13:77,784,808...77,822,333
|
|
G |
LOC687399 |
hypothetical protein LOC687399 |
decreases expression |
ISO |
Am 580 results in decreased expression of C16ORF46 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr19:49,508,321...49,518,721
Ensembl chr19:49,508,288...49,518,721
|
|
G |
Lrp11 |
LDL receptor related protein 11 |
decreases expression |
ISO |
Am 580 results in decreased expression of LRP11 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:1,702,696...1,731,210
Ensembl chr 1:1,702,696...1,731,210
|
|
G |
Man1c1 |
mannosidase, alpha, class 1C, member 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of MAN1C1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:152,775,031...152,920,130
Ensembl chr 5:152,774,855...152,920,343
|
|
G |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
decreases expression |
ISO |
Am 580 results in decreased expression of MAP3K6 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:151,435,679...151,448,329
Ensembl chr 5:151,436,464...151,448,328
|
|
G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of MAP4K1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:87,937,126...87,959,514
Ensembl chr 1:87,938,042...87,959,569
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in increased phosphorylation of and results in increased activity of MAPK1 protein |
CTD |
PMID:15383624 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in increased phosphorylation of and results in increased activity of MAPK3 protein |
CTD |
PMID:15383624 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Metrn |
meteorin, glial cell differentiation regulator |
decreases expression |
ISO |
Am 580 results in decreased expression of METRN mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:15,164,439...15,166,457
Ensembl chr10:15,164,439...15,166,457
|
|
G |
Mgat4c |
MGAT4 family, member C |
decreases expression |
ISO |
Am 580 results in decreased expression of MGAT4C mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:43,249,369...44,024,278
Ensembl chr 7:44,009,069...44,024,456
|
|
G |
Myorg |
myogenesis regulating glycosidase |
decreases expression |
ISO |
Am 580 results in decreased expression of MYORG mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:57,873,404...57,882,008
Ensembl chr 5:57,876,498...57,881,944
|
|
G |
Ndrg2 |
NDRG family member 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of NDRG2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr15:28,305,820...28,314,459
Ensembl chr15:28,305,821...28,314,459
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
increases expression |
ISO |
Am580 increases expression of Nphs1 mRNA in podocytes |
RGD |
PMID:22125642 |
RGD:40902998 |
NCBI chr 1:88,922,346...88,950,560
Ensembl chr 1:88,922,433...88,950,559
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions increases activity |
ISO |
Am 580 inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein] Am 580 results in increased activity of NR1H4 protein |
CTD |
PMID:25257666 |
|
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Nrip1 |
nuclear receptor interacting protein 1 |
increases expression |
ISO |
Am 580 results in increased expression of NRIP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr11:14,658,225...14,742,478
Ensembl chr11:14,658,225...14,741,563
|
|
G |
Nrip3 |
nuclear receptor interacting protein 3 |
increases expression |
ISO |
Am 580 results in increased expression of NRIP3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:174,385,424...174,411,141
Ensembl chr 1:174,385,424...174,411,141
|
|
G |
Nudt7 |
nudix hydrolase 7 |
decreases expression |
ISO |
Am 580 results in decreased expression of NUDT7 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr19:46,455,745...46,470,070
Ensembl chr19:46,455,761...46,482,050
|
|
G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
multiple interactions increases expression |
ISO |
Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of OAS2 mRNA] |
CTD |
PMID:16636311 |
|
NCBI chr12:41,341,417...41,363,124
Ensembl chr12:41,340,815...41,363,161
|
|
G |
Ocln |
occludin |
increases expression |
ISO |
Am 580 results in increased expression of OCLN mRNA |
CTD |
PMID:16982755 |
|
NCBI chr 2:30,527,327...30,577,218
Ensembl chr 2:30,527,715...30,577,218
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
increases expression |
ISO |
Am 580 results in increased expression of OLR1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:163,239,853...163,261,937
Ensembl chr 4:163,239,849...163,261,958
|
|
G |
Oma1 |
OMA1 zinc metallopeptidase |
increases expression |
ISO |
Am 580 results in increased expression of OMA1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:122,847,624...122,900,475
Ensembl chr 5:122,847,645...122,900,475
|
|
G |
Pald1 |
phosphatase domain containing, paladin 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of PALD1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr20:30,938,901...30,983,907
Ensembl chr20:30,938,901...30,975,472
|
|
G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
increases expression |
ISO |
Am 580 results in increased expression of PAPSS2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:251,145,264...251,230,716
Ensembl chr 1:251,145,253...251,230,715
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of PDLIM2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr15:51,843,562...51,856,785
Ensembl chr15:51,843,564...51,855,325
|
|
G |
Pdlim4 |
PDZ and LIM domain 4 |
decreases expression |
ISO |
Am 580 results in decreased expression of PDLIM4 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:39,390,578...39,405,322
Ensembl chr10:39,390,581...39,405,311
|
|
G |
Pheta1 |
PH domain containing endocytic trafficking adaptor 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of PHETA1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:40,225,316...40,230,573
Ensembl chr12:40,226,593...40,227,297
|
|
G |
Phlda2 |
pleckstrin homology-like domain, family A, member 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of PHLDA2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:216,701,345...216,704,479
Ensembl chr 1:216,702,319...216,703,534
|
|
G |
Plbd1 |
phospholipase B domain containing 1 |
increases expression |
ISO |
Am 580 results in increased expression of PLBD1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:170,564,387...170,620,681
Ensembl chr 4:170,564,367...170,620,703
|
|
G |
Plpp3 |
phospholipid phosphatase 3 |
increases expression |
ISO |
Am 580 results in increased expression of PLPP3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:124,690,214...124,765,499
Ensembl chr 5:124,690,214...124,765,498
|
|
G |
Pon2 |
paraoxonase 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of PON2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:30,344,705...30,380,119
Ensembl chr 4:30,344,709...30,380,119
|
|
G |
Pram1 |
PML-RARA regulated adaptor molecule 1 |
increases expression |
ISO |
Am 580 results in increased expression of PRAM1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 7:18,507,878...18,516,321
Ensembl chr 7:18,510,354...18,515,503
|
|
G |
Qprt |
quinolinate phosphoribosyltransferase |
decreases expression |
ISO |
Am 580 results in decreased expression of QPRT mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 1:198,544,262...198,559,556
Ensembl chr 1:198,544,262...198,559,568
|
|
G |
Rab15 |
RAB15, member RAS oncogene family |
decreases expression |
ISO |
Am 580 results in decreased expression of RAB15 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 6:99,845,952...99,870,320
Ensembl chr 6:99,845,954...99,870,024
|
|
G |
Rab20 |
RAB20, member RAS oncogene family |
increases expression |
ISO |
Am 580 results in increased expression of RAB20 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr16:83,358,116...83,382,326
Ensembl chr16:83,358,116...83,382,326
|
|
G |
Rap1gap |
Rap1 GTPase-activating protein |
decreases expression |
ISO |
Am 580 results in decreased expression of RAP1GAP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:156,008,868...156,074,350
Ensembl chr 5:156,026,911...156,074,395
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases expression decreases expression multiple interactions |
ISO |
Am 580 results in increased expression of RARA protein Am 580 results in decreased expression of RARA protein 2-bromopalmitate inhibits the reaction [Am 580 results in decreased expression of RARA protein]; Am 580 binds to and results in increased activity of RARA protein; Am 580 inhibits the reaction [Ro 41-5253 results in decreased activity of RARA protein] |
CTD |
PMID:10779427 PMID:16178010 PMID:16636311 PMID:17290005 PMID:30076181 |
|
NCBI chr10:86,838,819...86,884,224
Ensembl chr10:86,860,685...86,884,210
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in decreased phosphorylation of RB1 protein |
CTD |
PMID:15383624 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rbp1 |
retinol binding protein 1 |
increases expression |
ISO |
Am 580 results in increased expression of RBP1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 8:106,449,321...106,470,842
Ensembl chr 8:106,449,321...106,470,842
|
|
G |
Reps2 |
RALBP1 associated Eps domain containing 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of REPS2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr X:33,786,611...34,062,941
Ensembl chr X:33,884,499...34,057,399
|
|
G |
Rflnb |
refilin B |
increases expression |
ISO |
Am 580 results in increased expression of RFLNB mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:64,196,103...64,202,380
Ensembl chr10:64,196,127...64,202,380
|
|
G |
Rfxap |
regulatory factor X-associated protein |
decreases expression |
ISO |
Am 580 results in decreased expression of RFXAP mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:144,003,453...144,007,636
Ensembl chr 2:144,003,454...144,007,636
|
|
G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
increases expression |
ISO |
Am 580 results in increased expression of RHOBTB3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:2,627,655...2,683,305
Ensembl chr 2:2,627,393...2,683,116
|
|
G |
Rxra |
retinoid X receptor alpha |
increases activity |
ISO |
Am 580 results in increased activity of RXRA protein |
CTD |
PMID:21543282 |
|
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
|
|
G |
Sel1l3 |
SEL1L family member 3 |
increases expression |
ISO |
Am 580 results in increased expression of SEL1L3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr14:60,122,968...60,229,565
Ensembl chr14:60,123,169...60,229,734
|
|
G |
Selplg |
selectin P ligand |
decreases expression |
ISO |
Am 580 results in decreased expression of SELPLG mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:48,577,905...48,579,196
Ensembl chr12:48,577,905...48,579,196
|
|
G |
Slc26a11 |
solute carrier family 26 member 11 |
increases expression |
ISO |
Am 580 results in increased expression of SLC26A11 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:108,479,105...108,504,188
Ensembl chr10:108,480,368...108,503,706
|
|
G |
Slitrk4 |
SLIT and NTRK-like family, member 4 |
increases expression |
ISO |
Am 580 results in increased expression of SLITRK4 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr X:147,582,195...147,589,529
|
|
G |
Snai3 |
snail family transcriptional repressor 3 |
increases expression |
ISO |
Am 580 results in increased expression of SNAI3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr19:55,276,211...55,290,031
Ensembl chr19:55,277,549...55,284,663
|
|
G |
Ssmem1 |
serine-rich single-pass membrane protein 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of SSMEM1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:57,823,411...57,833,706
Ensembl chr 4:57,823,411...57,834,115
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
Am 580 results in increased phosphorylation of and results in increased activity of STAT1 protein; Ro 41-5253 inhibits the reaction [Am 580 results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:16085646 |
|
NCBI chr 9:54,287,540...54,327,958
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Sts |
steroid sulfatase |
increases activity |
ISO |
Am 580 results in increased activity of STS protein |
CTD |
PMID:16178010 |
|
NCBI chr X:45,420,418...45,428,748
Ensembl chr X:45,420,596...45,428,750
|
|
G |
Synpo |
synaptopodin |
increases expression |
ISO |
AM580 increases expression of Synpo mRNA in podocytes |
RGD |
PMID:22125642 |
RGD:40902998 |
NCBI chr18:55,863,081...55,921,412
Ensembl chr18:55,865,467...55,916,220
|
|
G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
decreases expression |
ISO |
Am 580 results in decreased expression of TACSTD2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 4:98,341,187...98,342,887
Ensembl chr 4:98,341,188...98,342,887
|
|
G |
Tbc1d2 |
TBC1 domain family, member 2 |
increases expression |
ISO |
Am 580 results in increased expression of TBC1D2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 5:62,213,001...62,261,467
Ensembl chr 5:62,212,982...62,260,105
|
|
G |
Tbl1x |
transducin (beta)-like 1 X-linked |
decreases expression |
ISO |
Am 580 results in decreased expression of TBL1X mRNA |
CTD |
PMID:16982809 |
|
NCBI chr X:44,959,883...44,988,551
Ensembl chr X:44,830,849...44,988,551
|
|
G |
Tbl2 |
transducin (beta)-like 2 |
increases expression |
ISO |
Am 580 results in increased expression of TBL2 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr12:24,565,843...24,578,855
Ensembl chr12:24,565,849...24,578,786
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions |
ISO |
[Am 580 co-treated with Retinoids] results in decreased expression of TERT mRNA |
CTD |
PMID:16482212 |
|
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tgm2 |
transglutaminase 2 |
multiple interactions increases activity increases expression |
ISO |
[Am 580 co-treated with CD 2425] results in increased activity of TGM2 protein Am 580 results in increased activity of TGM2 protein Am 580 results in increased expression of TGM2 mRNA |
CTD |
PMID:2884032 PMID:9516142 PMID:16982809 |
|
NCBI chr 3:154,597,165...154,627,257
Ensembl chr 3:154,597,168...154,627,257
|
|
G |
Thbs3 |
thrombospondin 3 |
increases expression |
ISO |
Am 580 results in increased expression of THBS3 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:188,528,979...188,540,738
Ensembl chr 2:188,528,979...188,540,736
|
|
G |
Tmem14a |
transmembrane protein 14A |
decreases expression |
ISO |
Am 580 results in decreased expression of TMEM14A mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:27,333,956...27,345,612 NCBI chr 9:27,334,103...27,351,302
Ensembl chr 9:27,343,853...27,345,070 Ensembl chr 9:27,343,853...27,345,070
|
|
G |
Tnf |
tumor necrosis factor |
increases activity |
ISO |
Am 580 results in increased activity of TNF protein |
CTD |
PMID:15703382 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
increases activity |
ISO |
Am 580 results in increased activity of TNFSF10 protein |
CTD |
PMID:15703382 |
|
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
|
|
G |
Tnfsf12 |
TNF superfamily member 12 |
decreases expression |
ISO |
Am 580 results in decreased expression of TNFSF12 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr10:56,290,780...56,300,137
Ensembl chr10:56,290,780...56,300,077
|
|
G |
Tns1 |
tensin 1 |
decreases expression |
ISO |
Am 580 results in decreased expression of TNS1 mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 9:81,190,192...81,401,020
Ensembl chr 9:81,194,119...81,400,987
|
|
G |
Zbtb7b |
zinc finger and BTB domain containing 7B |
decreases expression |
ISO |
Am 580 results in decreased expression of ZBTB7B mRNA |
CTD |
PMID:16982809 |
|
NCBI chr 2:188,704,989...188,719,674
Ensembl chr 2:188,704,687...188,718,704
|
|
|
G |
Esrrg |
estrogen-related receptor gamma |
multiple interactions |
ISO |
5,6,7,8-tetrahydro-2-naphthol binds to and results in increased activity of ESRRG protein; 5,6,7,8-tetrahydro-2-naphthol inhibits the reaction [afimoxifene binds to and results in decreased activity of ESRRG protein] |
CTD |
PMID:31127318 |
|
NCBI chr13:106,063,799...106,683,353
Ensembl chr13:106,463,368...106,683,436
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
5,6,7,8-tetrahydro-2-naphthol results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
|
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
multiple interactions |
ISO |
Nadolol inhibits the reaction [[CGP 12177 binds to ADRB1 protein] which results in increased abundance of Cyclic AMP] |
CTD |
PMID:15060759 |
|
NCBI chr 1:277,537,585...277,538,985
Ensembl chr 1:277,537,585...277,538,985
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
multiple interactions |
ISO |
[Nadolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP |
CTD |
PMID:17925438 |
|
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Nadolol co-treated with Mifepristone] promotes the reaction [methyldithiocarbamate promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]] |
CTD |
PMID:16321413 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
[Nadolol co-treated with Mifepristone] inhibits the reaction [methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]] |
CTD |
PMID:16321413 |
|
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions |
ISO |
Nadolol inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:21641380 |
|
NCBI chr 1:48,273,639...48,300,645
Ensembl chr 1:48,273,611...48,300,655
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
increases expression |
ISO |
LG100268 increases expression of abca1 protein in mouse hippocampus |
RGD |
PMID:25217640 |
RGD:21408550 |
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
|
|
|
G |
Adra1a |
adrenoceptor alpha 1A |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA1A protein] |
CTD |
PMID:16545797 |
|
NCBI chr15:43,296,997...43,398,314
Ensembl chr15:43,298,794...43,392,451
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions increases expression |
ISO |
acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of AIF1 protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of AIF1 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of AIF1 protein] |
CTD |
PMID:30366073 |
|
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of ARC mRNA] |
CTD |
PMID:19695244 |
|
NCBI chr 7:115,907,097...115,911,059
Ensembl chr 7:115,907,097...115,910,541
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of BAX protein acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of BAX protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of BAX protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of BAX protein] |
CTD |
PMID:30366073 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] |
CTD |
PMID:30366073 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] |
CTD |
PMID:30366073 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin results in increased cleavage of CASP3 protein acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased cleavage of CASP3 protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased cleavage of CASP3 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased cleavage of CASP3 protein] |
CTD |
PMID:30366073 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [CRH protein results in increased secretion of Serotonin] |
CTD |
PMID:14575894 |
|
NCBI chr 2:104,459,999...104,461,863
Ensembl chr 2:104,459,999...104,461,863
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of FOS mRNA]; 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Levodopa results in increased expression of FOS protein] 8-Hydroxy-2-(di-n-propylamino)tetralin affects the reaction [Haloperidol results in increased expression of FOS protein] |
CTD |
PMID:18585397 PMID:19115412 PMID:19695244 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of FOSB mRNA] |
CTD |
PMID:19695244 |
|
NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [[Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of GFAP protein] |
CTD |
PMID:23692952 |
|
NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
affects binding increases expression multiple interactions increases activity |
ISO EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein 8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA; 8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Morphine]; 8-fluoro-12-(4-methylpiperazin-1-yl)-6H-(1)benzothieno(2,3-b)(1,5)benzodiazepine affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin binds to and affects the activity of HTR1A protein; 8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of OXT protein modified form; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of POMC protein modified form; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to 1-(3-chlorophenyl)piperazine; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Apomorphine; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Morphine; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Physostigmine; [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in increased susceptibility to Serotonin; [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased activity of HTR1A protein] which results in decreased susceptibility to Pilocarpine; Cocaine inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein]; Diazinon promotes the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein]; Estradiol inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of OXT protein modified form]; Estradiol inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of POMC protein modified form]; Fluoxetine inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein]; Parathion inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein]; Streptozocin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased activity of HTR1A protein]; tertatolol inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Apomorphine]; tertatolol inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] which results in decreased susceptibility to Physostigmine] 8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide analog inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR1A protein] 8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]]; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]]; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein]; methamidophos inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin binds to HTR1A protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein]; NCF1 protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; NCF1 protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein]; PRKCD protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; PRKCD protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein] |
CTD |
PMID:2533336 PMID:8539317 PMID:9723786 PMID:9809859 PMID:10640309 PMID:10665824 PMID:11927170 PMID:12591222 PMID:14767715 PMID:15482641 PMID:15798786 PMID:15893579 PMID:16528294 PMID:17035140 PMID:17300168 PMID:18622176 PMID:19211973 PMID:20580787 PMID:21520940 PMID:21871486 PMID:22265196 PMID:30366073 |
|
NCBI chr 2:36,246,628...36,247,896
Ensembl chr 2:36,246,628...36,247,896
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in increased activity of HTR7 protein |
CTD |
PMID:15802305 |
|
NCBI chr 1:254,547,964...254,671,811
Ensembl chr 1:254,547,620...254,671,778
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases expression |
ISO |
acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IFNG protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IFNG protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IFNG protein] |
CTD |
PMID:30366073 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Lipopolysaccharides results in increased secretion of IL12B protein] |
CTD |
PMID:15802305 |
|
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [[Sarin co-treated with 2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide] results in increased expression of IL1B protein] |
CTD |
PMID:15802305 PMID:23692952 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] 8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IL6 protein acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IL6 protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IL6 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of IL6 protein] |
CTD |
PMID:15802305 PMID:30366073 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of JUNB mRNA] |
CTD |
PMID:19695244 |
|
NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin results in increased phosphorylation of and affects the localization of NCF1 protein; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]]; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased phosphorylation of and affects the localization of NCF1 protein]; NCF1 protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; NCF1 protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein]; PRKCD protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased phosphorylation of and affects the localization of NCF1 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to HTR1A protein]]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased phosphorylation of and affects the localization of NCF1 protein] |
CTD |
PMID:30366073 |
|
NCBI chr12:25,497,104...25,506,300
Ensembl chr12:25,497,104...25,506,300
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of NR4A1 mRNA] |
CTD |
PMID:19695244 |
|
NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
|
|
G |
Oxt |
oxytocin/neurophysin I prepropeptide |
multiple interactions |
EXP |
[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of OXT protein modified form; Estradiol inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of OXT protein modified form] |
CTD |
PMID:22265196 |
|
NCBI chr 3:123,106,694...123,107,534
Ensembl chr 3:123,106,694...123,107,534
|
|
G |
Pdyn |
prodynorphin |
multiple interactions |
EXP |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Levodopa results in increased expression of PDYN mRNA] |
CTD |
PMID:19115412 |
|
NCBI chr 3:122,194,327...122,206,671
Ensembl chr 3:122,194,329...122,206,671
|
|
G |
Pomc |
proopiomelanocortin |
multiple interactions |
EXP |
[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of POMC protein modified form; Estradiol inhibits the reaction [[8-Hydroxy-2-(di-n-propylamino)tetralin binds to and results in decreased activity of HTR1A protein] which results in increased expression of POMC protein modified form] |
CTD |
PMID:22265196 |
|
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
G |
Prkcd |
protein kinase C, delta |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]; 8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of and results in increased phosphorylation of PRKCD protein; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]]; acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]]; PRKCD protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A mRNA]; PRKCD protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of HTR1A protein]; PRKCD protein affects the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased phosphorylation of and affects the localization of NCF1 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [NCF1 protein binds to PRKCD protein]]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin promotes the reaction [PRKCD protein binds to HTR1A protein]] |
CTD |
PMID:30366073 |
|
NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
ISO |
acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of PTGS2 protein]; N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of PTGS2 protein]; rottlerin inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in increased expression of PTGS2 protein] |
CTD |
PMID:30366073 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
increases response to substance |
EXP |
SLC6A4 results in increased susceptibility to 8-Hydroxy-2-(di-n-propylamino)tetralin |
CTD |
PMID:18581099 |
|
NCBI chr10:63,153,656...63,188,377
Ensembl chr10:63,153,651...63,176,463
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:15802305 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
|
G |
Oprk1 |
opioid receptor, kappa 1 |
multiple interactions affects binding |
EXP |
Cadmium inhibits the reaction [Ethylketocyclazocine binds to OPRK1 protein]; Copper inhibits the reaction [Ethylketocyclazocine binds to OPRK1 protein]; Mercury inhibits the reaction [Ethylketocyclazocine binds to OPRK1 protein] |
CTD |
PMID:2162496 |
|
NCBI chr 5:13,742,655...13,760,460
Ensembl chr 5:13,744,658...13,760,305
|
|
|
G |
Ar |
androgen receptor |
increases expression |
EXP |
Lasofoxifene results in increased expression of AR protein |
CTD |
PMID:16837883 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Areg |
amphiregulin |
multiple interactions increases expression |
ISO |
Lasofoxifene inhibits the reaction [Estrogens, Conjugated (USP) results in increased expression of AREG mRNA] Lasofoxifene results in increased expression of AREG mRNA |
CTD |
PMID:19022889 |
|
NCBI chr14:18,521,921...18,531,179
Ensembl chr14:18,521,930...18,531,179
|
|
G |
Defb1 |
defensin beta 1 |
multiple interactions |
ISO |
[Progesterone co-treated with Lasofoxifene] results in increased expression of DEFB1 mRNA |
CTD |
PMID:18367319 |
|
NCBI chr16:75,294,385...75,309,127
Ensembl chr16:75,294,376...75,309,176
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
EXP |
Lasofoxifene results in increased expression of ESR2 protein |
CTD |
PMID:16837883 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
increases expression multiple interactions |
ISO |
Lasofoxifene results in increased expression of IDO1 mRNA Lasofoxifene inhibits the reaction [Estradiol results in increased expression of IDO1 mRNA] |
CTD |
PMID:18367319 |
|
NCBI chr16:72,216,326...72,228,098
Ensembl chr16:72,216,326...72,228,098
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases activity |
EXP |
Lasofoxifene results in increased activity of MMP2 protein |
CTD |
PMID:15576828 |
|
NCBI chr19:15,542,771...15,570,589
Ensembl chr19:15,542,765...15,570,611
|
|
G |
P2ry14 |
purinergic receptor P2Y14 |
multiple interactions |
ISO |
Lasofoxifene inhibits the reaction [Estradiol results in increased expression of P2RY14 mRNA] |
CTD |
PMID:18367319 |
|
NCBI chr 2:149,331,948...149,379,336
Ensembl chr 2:149,331,948...149,347,796
|
|
G |
Pgr |
progesterone receptor |
increases expression |
EXP |
Lasofoxifene results in increased expression of PGR protein |
CTD |
PMID:16837883 |
|
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Spink1 |
serine peptidase inhibitor, Kazal type 1 |
multiple interactions |
ISO |
[Progesterone co-treated with Lasofoxifene] results in increased expression of SPINK1 mRNA |
CTD |
PMID:18367319 |
|
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
|
|
|
G |
RT1-DMb |
RT1 class II, locus DMb |
affects expression |
ISO |
Levobunolol affects the expression of HLA-DMB mRNA |
CTD |
PMID:25811541 |
|
NCBI chr20:3,945,383...3,952,838
Ensembl chr20:5,227,045...5,234,290
|
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
liranaftate results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
G |
Tslp |
thymic stromal lymphopoietin |
decreases expression decreases expression |
ISO |
Liranaftate decreases expression of TSLP mRNA in epidermal keratinocytes Liranaftate decreases expression of Tslp mRNA in ear skin |
RGD |
PMID:30187507, PMID:30187507 |
RGD:38596345, RGD:38596345 |
NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity |
ISO |
Mibefradil results in decreased activity of ABCB11 protein |
CTD |
PMID:20829430 |
|
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
Mibefradil inhibits the reaction [AGT protein results in increased abundance of Aldosterone]; Mibefradil inhibits the reaction [AGT protein results in increased expression of CYP11B2 mRNA]; Mibefradil inhibits the reaction [AGT protein results in increased uptake of Calcium] |
CTD |
PMID:18331727 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
affects response to substance multiple interactions |
ISO EXP |
CACNA1G protein affects the susceptibility to Mibefradil Mibefradil inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] |
CTD |
PMID:12130671 PMID:17110049 |
|
NCBI chr10:82,129,071...82,197,828
Ensembl chr10:82,129,506...82,197,848
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
multiple interactions |
EXP ISO |
Mibefradil inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] Mibefradil inhibits the reaction [CACNA1H protein results in increased transport of Calcium] |
CTD |
PMID:9930755 PMID:17110049 |
|
NCBI chr10:14,730,932...14,789,201
Ensembl chr10:14,730,941...14,788,617
|
|
G |
Cacna1i |
calcium voltage-gated channel subunit alpha1 I |
multiple interactions |
EXP |
Mibefradil inhibits the reaction [[Colforsin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1I protein] |
CTD |
PMID:17110049 |
|
NCBI chr 7:121,521,787...121,619,300
Ensembl chr 7:121,511,097...121,619,283
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
multiple interactions |
EXP |
Mibefradil inhibits the reaction [Potassium results in increased secretion of CALCA protein] |
CTD |
PMID:18178321 |
|
NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911
|
|
G |
Cyp11b3 |
cytochrome P450, family 11, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
Mibefradil inhibits the reaction [AGT protein results in increased expression of CYP11B2 mRNA] |
CTD |
PMID:18331727 |
|
NCBI chr 7:116,155,928...116,161,781
Ensembl chr 7:116,156,219...116,255,167
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
decreases activity |
ISO |
Mibefradil results in decreased activity of CYP3A4 protein |
CTD |
PMID:15860655 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
EXP |
Mibefradil inhibits the reaction [[Sodium Chloride, Dietary co-treated with Desoxycorticosterone] results in increased expression of EDN1 mRNA] |
CTD |
PMID:8934362 |
|
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Hexa |
hexosaminidase subunit alpha |
multiple interactions |
EXP |
Mibefradil inhibits the reaction [Tetrachlorodibenzodioxin results in increased secretion of [HEXB protein binds to HEXA protein]] |
CTD |
PMID:19546254 |
|
NCBI chr 8:64,325,435...64,350,775
Ensembl chr 8:64,325,435...64,350,773
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
Mibefradil inhibits the reaction [Tetrachlorodibenzodioxin results in increased secretion of [HEXB protein binds to HEXA protein]] |
CTD |
PMID:19546254 |
|
NCBI chr 2:27,983,925...28,003,260
Ensembl chr 2:27,984,117...28,003,186
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions decreases activity |
ISO |
Mibefradil inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Mibefradil results in decreased activity of KCNH2 protein |
CTD |
PMID:21158687 PMID:28551711 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
G |
Lamp1 |
lysosomal-associated membrane protein 1 |
multiple interactions |
EXP |
Mibefradil inhibits the reaction [Tetrachlorodibenzodioxin results in increased secretion of LAMP1 protein] |
CTD |
PMID:19546254 |
|
NCBI chr16:81,689,576...81,714,341
Ensembl chr16:81,689,335...81,714,419
|
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
rotigotine results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases activity |
ISO |
Sertraline results in increased activity of ABCB1 protein |
CTD |
PMID:23273999 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
Sertraline inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:17728140 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Sertraline binds to ALB protein |
CTD |
PMID:26471709 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
increases expression |
ISO |
Sertraline results in increased expression of ASAH1 mRNA |
CTD |
PMID:15342952 |
|
NCBI chr16:53,998,604...54,030,006
Ensembl chr16:53,998,560...54,040,836
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
Sertraline results in increased expression of ASNS mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 4:33,742,876...33,761,106
Ensembl chr 4:33,743,364...33,761,163
|
|
G |
Atf2 |
activating transcription factor 2 |
increases expression |
ISO |
Sertraline results in increased expression of ATF2 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 3:60,721,137...60,795,951
Ensembl chr 3:60,721,135...60,795,951
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Sertraline results in increased expression of ATF4 protein |
CTD |
PMID:24865413 |
|
NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression decreases expression |
ISO |
Sertraline affects the expression of BCL2 protein Sertraline results in decreased expression of BCL2 protein |
CTD |
PMID:18403212 PMID:24194395 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
Sertraline results in increased expression of BDNF protein |
CTD |
PMID:18403212 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP3 protein]; Sertraline results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:24194395 PMID:24865413 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp4 |
caspase 4 |
increases cleavage multiple interactions |
ISO |
Sertraline results in increased cleavage of CASP4 protein MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein] |
CTD |
PMID:24865413 |
|
NCBI chr 8:2,616,391...2,651,682
Ensembl chr 8:2,635,851...2,651,652
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP7 protein] |
CTD |
PMID:24865413 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
Sertraline results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:24194395 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Nitric Oxide promotes the reaction [Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein]]; Sertraline inhibits the reaction [3-nitropropionic acid results in decreased activity of CAT protein] |
CTD |
PMID:20305041 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cd14 |
CD14 molecule |
decreases expression |
ISO |
Sertraline results in decreased expression of CD14 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression |
EXP |
Sertraline results in increased expression of CREB1 mRNA |
CTD |
PMID:8601816 |
|
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
|
|
G |
Cryaa |
crystallin, alpha A |
increases expression |
ISO |
Sertraline results in increased expression of CRYAA mRNA |
CTD |
PMID:24865413 |
|
NCBI chr20:10,438,444...10,442,189
Ensembl chr20:10,438,444...10,442,187
|
|
G |
Cul1 |
cullin 1 |
decreases expression |
ISO |
Sertraline results in decreased expression of CUL1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 4:77,211,814...77,283,369
Ensembl chr 4:77,211,692...77,280,250
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Sertraline results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:29850907 |
|
NCBI chr 8:62,798,317...62,809,848
Ensembl chr 8:62,779,875...62,809,893
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Sertraline results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:29850907 |
|
NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Sertraline results in decreased activity of CYP19A1 protein |
CTD |
PMID:26162595 |
|
NCBI chr 8:58,744,849...58,772,408
Ensembl chr 8:58,744,849...58,772,408
|
|
G |
Cyp21a1 |
cytochrome P450, family 21, subfamily a, polypeptide 1 |
decreases expression |
EXP |
Sertraline results in decreased expression of CYP21A1 mRNA |
CTD |
PMID:29850907 |
|
NCBI chr20:4,486,213...4,489,358
Ensembl chr20:4,486,219...4,489,550
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions decreases activity |
ISO |
[Sertraline results in decreased activity of CYP2B6 protein] which results in decreased metabolism of Bupropion; CYP2B6 protein results in decreased methylation of and results in increased metabolism of Sertraline |
CTD |
PMID:15547048 PMID:26599973 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
affects metabolic processing increases metabolic processing decreases methylation multiple interactions |
ISO |
CYP2C19 gene polymorphism affects the metabolism of Sertraline CYP2C19 protein results in increased metabolism of Sertraline CYP2C19 protein results in decreased methylation of Sertraline CYP2C19 protein results in decreased amination of and results in increased metabolism of Sertraline; CYP2C19 protein results in decreased methylation of and results in increased metabolism of Sertraline |
CTD |
PMID:11452243 PMID:15547048 |
|
NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions |
ISO |
CYP2D6 protein results in decreased methylation of and results in increased metabolism of Sertraline |
CTD |
PMID:15547048 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
multiple interactions |
ISO |
CYP3A4 protein results in decreased amination of and results in increased metabolism of Sertraline; CYP3A4 protein results in decreased methylation of and results in increased metabolism of Sertraline; Sertraline promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin] |
CTD |
PMID:15547048 PMID:19299527 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Dbh |
dopamine beta-hydroxylase |
increases response to substance |
ISO |
DBH protein results in increased susceptibility to Sertraline |
CTD |
PMID:15148402 |
|
NCBI chr 3:5,709,236...5,731,895
Ensembl chr 3:5,709,236...5,731,898
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
4-phenylbutyric acid inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased expression of DDIT3 protein] Sertraline results in increased expression of DDIT3 mRNA; Sertraline results in increased expression of DDIT3 protein |
CTD |
PMID:24865413 |
|
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Depp1 |
DEPP1, autophagy regulator |
increases expression |
ISO |
Sertraline results in increased expression of DEPP1 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 4:148,780,330...148,784,566
Ensembl chr 4:148,782,479...148,784,562
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
increases expression |
ISO |
Sertraline results in increased expression of DNAJC5 mRNA; Sertraline results in increased expression of DNAJC5 protein |
CTD |
PMID:11257428 |
|
NCBI chr 3:177,012,714...177,047,787
Ensembl chr 3:177,013,604...177,043,902
|
|
G |
Drd1 |
dopamine receptor D1 |
increases expression |
EXP |
Sertraline results in increased expression of DRD1 mRNA |
CTD |
PMID:16499906 |
|
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Sertraline results in increased expression of DUSP1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
ISO |
Sertraline results in increased expression of DUSP10 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
|
|
G |
Dusp14 |
dual specificity phosphatase 14 |
increases expression |
ISO |
Sertraline results in increased expression of DUSP14 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr10:71,363,688...71,383,602
Ensembl chr10:71,363,688...71,383,602
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
increases expression |
ISO |
Sertraline results in increased expression of DUSP16 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 4:168,470,141...168,551,346
Ensembl chr 4:168,472,412...168,517,177
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
increases expression |
ISO |
Sertraline results in increased expression of DUSP8 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:215,030,429...215,043,111
Ensembl chr 1:215,030,429...215,033,460
|
|
G |
Egfr |
epidermal growth factor receptor |
increases expression |
ISO |
Sertraline results in increased expression of EGFR mRNA |
CTD |
PMID:24865413 |
|
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases expression |
ISO |
MAP4K4 mutant form inhibits the reaction [Sertraline results in increased phosphorylation of EIF2AK3 protein]; Sertraline results in increased expression of and results in increased phosphorylation of EIF2AK3 protein Sertraline results in increased expression of EIF2AK3 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 4:98,648,513...98,709,695
Ensembl chr 4:98,648,545...98,709,694
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
ISO |
Sertraline results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:24865413 |
|
NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression |
ISO |
Sertraline results in increased expression of ERN1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
ISO |
Sertraline results in increased expression of FABP1 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 4:99,063,181...99,066,957
Ensembl chr 4:99,063,181...99,066,954
|
|
G |
Fndc4 |
fibronectin type III domain containing 4 |
increases expression |
ISO |
Sertraline results in increased expression of FNDC4 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 6:26,387,284...26,389,524
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression increases expression |
EXP ISO |
Sertraline results in decreased expression of FOS mRNA Sertraline results in increased expression of FOS mRNA |
CTD |
PMID:7612155 PMID:24865413 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
Sertraline results in increased expression of GADD45A mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
Sertraline results in increased expression of GADD45B mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 7:11,646,283...11,648,338
Ensembl chr 7:11,646,269...11,648,322
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
increases expression |
ISO |
Sertraline results in increased expression of GDPD3 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 1:198,199,032...198,209,178
Ensembl chr 1:198,199,622...198,209,150
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
increases expression |
ISO |
Sertraline results in increased expression of HERPUD1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr19:11,046,905...11,057,440
Ensembl chr19:11,046,909...11,057,254
|
|
G |
Hpn |
hepsin |
increases expression |
ISO |
Sertraline results in increased expression of HPN mRNA |
CTD |
PMID:15342952 |
|
NCBI chr 1:89,534,112...89,549,575
Ensembl chr 1:89,534,106...89,543,967
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
EXP |
Sertraline results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:29850907 |
|
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
increases expression |
ISO |
Sertraline results in increased expression of HSPA1A mRNA |
CTD |
PMID:24865413 |
|
NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
ISO |
Sertraline results in increased expression of HSPA1B mRNA |
CTD |
PMID:24865413 |
|
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
increases expression decreases expression |
EXP ISO |
Sertraline results in increased expression of HSPA8 mRNA alternative form; Sertraline results in increased expression of HSPA8 protein alternative form Sertraline results in decreased expression of HSPA8 mRNA |
CTD |
PMID:10425221 PMID:24865413 |
|
NCBI chr 8:44,989,401...44,993,261
Ensembl chr 8:44,990,014...44,993,179
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
multiple interactions increases expression |
EXP |
[Estradiol co-treated with Sertraline] affects the expression of HTR1A mRNA Sertraline results in increased expression of HTR1A mRNA |
CTD |
PMID:18650020 |
|
NCBI chr 2:36,246,628...36,247,896
Ensembl chr 2:36,246,628...36,247,896
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions increases expression |
EXP |
[Estradiol co-treated with Sertraline] affects the expression of HTR2A mRNA; Estradiol promotes the reaction [Sertraline results in increased expression of HTR2A mRNA] |
CTD |
PMID:18650020 |
|
NCBI chr15:56,666,152...56,732,469
Ensembl chr15:56,666,012...56,735,382
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
multiple interactions increases expression |
EXP |
[Estradiol co-treated with Sertraline] affects the expression of HTR2C mRNA; Estradiol promotes the reaction [Sertraline results in increased expression of HTR2C mRNA] |
CTD |
PMID:18650020 |
|
NCBI chr X:118,084,520...118,318,040
Ensembl chr X:118,084,890...118,318,039
|
|
G |
Inhbe |
inhibin subunit beta E |
increases expression |
ISO |
Sertraline results in increased expression of INHBE mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 7:70,641,423...70,642,848
Ensembl chr 7:70,640,075...70,643,169
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
EXP |
Sertraline affects the reaction [INS protein affects the phosphorylation of IRS1 protein]; Sertraline inhibits the reaction [INS protein results in increased phosphorylation of and results in increased activity of AKT1 protein] |
CTD |
PMID:17728140 |
|
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions decreases activity |
EXP |
Sertraline affects the reaction [INS protein affects the phosphorylation of IRS1 protein] Sertraline results in decreased activity of IRS1 protein |
CTD |
PMID:17728140 |
|
NCBI chr 9:88,033,668...88,086,488
Ensembl chr 9:88,033,668...88,086,488
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
Sertraline results in increased expression of and results in increased phosphorylation of JUN protein Sertraline results in increased expression of JUN mRNA |
CTD |
PMID:24194395 PMID:24865413 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Jund |
JunD proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Sertraline results in increased expression of JUND mRNA |
CTD |
PMID:24865413 |
|
NCBI chr16:20,485,028...20,486,707
Ensembl chr16:20,485,029...20,486,707
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Sertraline results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
multiple interactions |
ISO |
Sertraline inhibits the reaction [Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA] |
CTD |
PMID:22164246 |
|
NCBI chr 3:41,019,898...41,181,070
Ensembl chr 3:41,019,898...41,181,070
|
|
G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
multiple interactions |
ISO |
Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA] |
CTD |
PMID:22164246 |
|
NCBI chr 8:33,435,493...33,463,410
Ensembl chr 8:33,433,905...33,463,467
|
|
G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
multiple interactions |
ISO |
Sertraline inhibits the reaction [Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA] |
CTD |
PMID:22164246 |
|
NCBI chr11:35,011,007...35,262,362
Ensembl chr11:35,024,196...35,099,383
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression |
EXP |
Sertraline results in increased expression of LHB protein |
CTD |
PMID:29850907 |
|
NCBI chr 1:101,409,992...101,413,725
Ensembl chr 1:101,410,019...101,413,724
|
|
G |
LOC299277 |
similar to serine (or cysteine) peptidase inhibitor, clade A, member 3B |
increases expression |
ISO |
Sertraline results in increased expression of SERPINA3 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 6:127,871,895...127,888,287
Ensembl chr 6:127,872,666...127,886,540
|
|
G |
LOC686035 |
similar to heat shock 70kDa protein 6 (HSP70B) |
increases expression |
ISO |
Sertraline results in increased expression of HSPA6 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr13:89,408,703...89,411,500
|
|
G |
Lss |
lanosterol synthase |
increases expression |
ISO |
Sertraline results in increased expression of LSS mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr20:12,844,522...12,870,474
Ensembl chr20:12,842,884...12,870,497
|
|
G |
Maoa |
monoamine oxidase A |
multiple interactions |
ISO |
MAOA protein results in decreased amination of and results in increased metabolism of Sertraline |
CTD |
PMID:15547048 |
|
NCBI chr X:6,554,698...6,620,722
Ensembl chr X:6,554,698...6,620,722
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
ISO |
MAOB protein results in decreased amination of and results in increased metabolism of Sertraline |
CTD |
PMID:15547048 |
|
NCBI chr X:6,430,694...6,533,520
Ensembl chr X:6,430,594...6,533,534
|
|
G |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
increases expression |
ISO |
Sertraline results in increased expression of MAP3K13 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr11:82,744,391...82,938,357
Ensembl chr11:82,745,735...82,938,357
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
increases expression |
ISO |
Sertraline results in increased expression of MAP3K8 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr17:56,109,403...56,129,925
Ensembl chr17:56,109,549...56,129,919
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
multiple interactions decreases expression |
ISO |
MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased phosphorylation of EIF2AK3 protein] Sertraline results in decreased expression of MAP4K4 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 9:46,657,444...46,782,545
Ensembl chr 9:46,657,575...46,782,545
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Sertraline results in increased phosphorylation of and results in increased activity of MAPK1 protein Sertraline results in increased phosphorylation of MAPK1 protein 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Sertraline results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:17728140 PMID:24194395 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Sertraline results in increased phosphorylation of and results in increased activity of MAPK3 protein Sertraline results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:17728140 PMID:24194395 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
pyrazolanthrone inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of MAPK8 protein]; Sertraline results in increased phosphorylation of and results in increased activity of MAPK8 protein |
CTD |
PMID:17728140 |
|
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
increases expression |
ISO |
Sertraline results in increased expression of MAPK8IP3 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr10:14,259,394...14,299,276
Ensembl chr10:14,260,787...14,299,167
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
ISO |
Sertraline results in decreased expression of MCL1 protein |
CTD |
PMID:24194395 |
|
NCBI chr 2:197,786,212...197,788,992
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Sertraline results in increased expression of MYC mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
increases expression |
ISO |
Sertraline results in increased expression of NFE2L2 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression |
ISO |
Sertraline results in increased expression of NFKB1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nfkb2 |
nuclear factor kappa B subunit 2 |
increases expression |
ISO |
Sertraline results in increased expression of NFKB2 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:266,050,634...266,059,277
Ensembl chr 1:266,053,002...266,059,256
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
increases expression |
ISO |
Sertraline results in increased expression of NR0B2 mRNA |
CTD |
PMID:15342952 |
|
NCBI chr 5:151,776,004...151,779,319
Ensembl chr 5:151,776,004...151,779,319
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
increases expression |
ISO |
Sertraline results in increased expression of NUPR1 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 1:194,767,484...194,769,519
Ensembl chr 1:194,767,474...194,769,524
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression |
ISO |
Sertraline results in decreased expression of PECAM1 protein |
CTD |
PMID:15932816 |
|
NCBI chr10:94,850,971...94,913,202
|
|
G |
Pf4 |
platelet factor 4 |
decreases expression |
ISO |
Sertraline results in decreased expression of PF4 protein |
CTD |
PMID:15932816 |
|
NCBI chr14:18,848,549...18,849,258
Ensembl chr14:18,848,549...18,849,258
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
increases expression |
ISO |
Sertraline results in increased expression of PHYH mRNA |
CTD |
PMID:15342952 |
|
NCBI chr17:77,287,580...77,304,482
Ensembl chr17:77,287,188...77,304,530
|
|
G |
Ppbp |
pro-platelet basic protein |
decreases expression |
ISO |
Sertraline results in decreased expression of PPBP protein |
CTD |
PMID:12912814 |
|
NCBI chr14:18,852,433...18,853,237
Ensembl chr14:18,851,954...18,853,315
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
Sertraline results in increased expression of PPP1R15A mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Sertraline results in decreased expression of PTGS2 mRNA; Sertraline results in decreased expression of PTGS2 protein |
CTD |
PMID:17499975 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Rbx1 |
ring-box 1 |
decreases expression |
ISO |
Sertraline results in decreased expression of RBX1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 7:122,700,849...122,710,907
Ensembl chr 7:122,700,854...122,709,935
|
|
G |
Relb |
RELB proto-oncogene, NF-kB subunit |
increases expression |
ISO |
Sertraline results in increased expression of RELB mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:80,517,081...80,545,019
Ensembl chr 1:80,517,411...80,544,825
|
|
G |
Rnf103 |
ring finger protein 103 |
increases expression |
EXP |
Sertraline results in increased expression of RNF103 mRNA |
CTD |
PMID:11071867 |
|
NCBI chr 4:99,398,479...99,415,193
Ensembl chr 4:99,398,494...99,421,164
|
|
G |
Rps6ka3 |
ribosomal protein S6 kinase A3 |
decreases expression |
ISO |
Sertraline results in decreased expression of RPS6KA3 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr X:37,469,736...37,576,055
Ensembl chr X:37,469,937...37,575,624
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP |
Sertraline results in increased phosphorylation of and results in increased activity of RPS6KB1 protein; Sirolimus inhibits the reaction [Sertraline results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:17728140 |
|
NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364
|
|
G |
Sec61g |
SEC61 translocon subunit gamma |
decreases expression |
ISO |
Sertraline results in decreased expression of SEC61G mRNA |
CTD |
PMID:24865413 |
|
NCBI chr14:99,774,589...99,780,964
Ensembl chr14:99,774,589...99,780,964
|
|
G |
Sele |
selectin E |
decreases expression |
ISO |
Sertraline results in decreased expression of SELE protein |
CTD |
PMID:12912814 PMID:15932816 |
|
NCBI chr13:82,355,234...82,365,323
Ensembl chr13:82,355,471...82,365,341
|
|
G |
Selenos |
selenoprotein S |
increases expression |
ISO |
Sertraline results in increased expression of SELS mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:126,979,579...126,989,344
Ensembl chr 1:126,979,575...126,989,344
|
|
G |
Selp |
selectin P |
decreases expression |
ISO |
Sertraline results in decreased expression of SELP protein |
CTD |
PMID:12912814 PMID:15932816 |
|
NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628
|
|
G |
Serpini1 |
serpin family I member 1 |
increases expression |
EXP |
Sertraline results in increased expression of SERPINI1 mRNA |
CTD |
PMID:16637596 |
|
NCBI chr 2:174,013,058...174,111,693
Ensembl chr 2:174,013,288...174,111,752
|
|
G |
Skp1 |
S-phase kinase-associated protein 1 |
decreases expression |
ISO |
Sertraline results in decreased expression of SKP1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr10:37,594,578...37,609,498
Ensembl chr10:37,594,578...37,609,498
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
decreases expression |
ISO |
Sertraline results in decreased expression of SLC2A3 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr 4:155,549,991...155,626,018
Ensembl chr 4:155,408,233...155,631,856
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
multiple interactions increases expression decreases expression affects response to substance increases response to substance |
ISO EXP |
Sertraline inhibits the reaction [Monocrotaline results in increased expression of SLC6A4 mRNA] Sertraline results in increased expression of SLC6A4 mRNA Sertraline results in decreased expression of SLC6A4 protein SLC6A4 protein affects the susceptibility to Sertraline [Estradiol co-treated with Sertraline] affects the expression of SLC6A4 mRNA; [Sertraline results in decreased expression of SLC6A4 protein] which results in decreased metabolism of Serotonin Uptake Inhibitors; Estradiol promotes the reaction [Sertraline results in increased expression of SLC6A4 mRNA] SLC6A4 promoter polymorphism results in increased susceptibility to Sertraline |
CTD |
PMID:12151556 PMID:12955294 PMID:17042913 PMID:18650020 PMID:18923402 |
|
NCBI chr10:63,153,656...63,188,377
Ensembl chr10:63,153,651...63,176,463
|
|
G |
Ssr2 |
signal sequence receptor subunit 2 |
increases expression |
ISO |
Sertraline results in increased expression of SSR2 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 2:187,951,316...187,960,067
Ensembl chr 2:187,951,344...187,960,063
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression |
EXP |
Sertraline results in decreased expression of STAR mRNA |
CTD |
PMID:29850907 |
|
NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases expression |
ISO |
Sertraline results in decreased expression of STAT3 mRNA; Sertraline results in decreased expression of STAT3 protein |
CTD |
PMID:17499975 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression |
ISO |
Sertraline results in decreased expression of STMN1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 5:152,680,412...152,686,807
Ensembl chr 5:152,680,407...152,686,806
|
|
G |
Syvn1 |
synoviolin 1 |
increases expression |
ISO |
Sertraline results in increased expression of SYVN1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:221,409,281...221,416,229
Ensembl chr 1:221,409,271...221,417,886
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
Sertraline results in decreased expression of TAGLN mRNA |
CTD |
PMID:15342952 |
|
NCBI chr 8:50,222,895...50,228,369
Ensembl chr 8:50,222,896...50,231,357
|
|
G |
Taok2 |
TAO kinase 2 |
increases expression |
ISO |
Sertraline results in increased expression of TAOK2 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 1:198,301,789...198,354,601
Ensembl chr 1:198,301,938...198,320,075
|
|
G |
Tfap2a |
transcription factor AP-2 alpha |
increases expression |
ISO |
Sertraline results in increased expression of TFAP2A protein |
CTD |
PMID:28844482 |
|
NCBI chr17:24,653,342...24,670,457
Ensembl chr17:24,654,902...24,670,457
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion increases expression |
ISO |
Sertraline results in decreased secretion of TNF protein Sertraline results in increased expression of TNF mRNA |
CTD |
PMID:17499975 PMID:24194395 PMID:24865413 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tph2 |
tryptophan hydroxylase 2 |
multiple interactions increases expression increases activity |
EXP |
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Sertraline results in increased expression of TPH2 mRNA] Sertraline results in increased expression of TPH2 mRNA; Sertraline results in increased expression of TPH2 protein Sertraline results in increased activity of TPH2 protein |
CTD |
PMID:11901216 |
|
NCBI chr 7:58,042,279...58,149,220
Ensembl chr 7:58,042,281...58,149,061
|
|
G |
Txndc5 |
thioredoxin domain containing 5 |
decreases expression |
ISO |
Sertraline results in decreased expression of TXNDC5 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr17:26,925,828...26,953,981
Ensembl chr17:26,925,828...26,953,970
|
|
G |
Ube2d4 |
ubiquitin-conjugating enzyme E2D 4 (putative) |
decreases expression |
ISO |
Sertraline results in decreased expression of UBE2D4 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr14:2,933,097...2,934,571
Ensembl chr14:2,933,100...2,934,571
|
|
G |
Ube2g1 |
ubiquitin-conjugating enzyme E2G 1 |
decreases expression |
ISO |
Sertraline results in decreased expression of UBE2G1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr10:59,173,268...59,254,458
Ensembl chr10:59,173,268...59,254,453
|
|
G |
Ube4b |
ubiquitination factor E4B |
decreases expression |
ISO |
Sertraline results in decreased expression of UBE4B mRNA |
CTD |
PMID:24865413 |
|
NCBI chr 5:166,156,033...166,259,069
Ensembl chr 5:166,156,033...166,259,069
|
|
G |
Ubqln1 |
ubiquilin 1 |
increases expression |
ISO |
Sertraline results in increased expression of UBQLN1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr17:6,840,441...6,878,842
Ensembl chr17:6,840,463...6,878,844
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions |
ISO |
UGT2B7 protein results in increased glucuronidation of and results in increased metabolism of Sertraline |
CTD |
PMID:15547048 |
|
NCBI chr14:22,597,103...22,619,968
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
increases expression |
ISO |
Sertraline results in increased expression of VCAM1 protein |
CTD |
PMID:15932816 |
|
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
increases expression |
ISO |
Sertraline results in increased expression of WIPI1 mRNA |
CTD |
PMID:15342952 PMID:17567588 |
|
NCBI chr10:97,859,730...97,896,949
Ensembl chr10:97,859,727...97,896,525
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases splicing |
ISO |
Sertraline results in increased splicing of XBP1 mRNA |
CTD |
PMID:24865413 |
|
NCBI chr14:85,753,736...85,758,820
Ensembl chr14:85,753,760...85,758,145
|
|
|
G |
Acan |
aggrecan |
affects expression |
ISO |
tamibarotene affects the expression of ACAN mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:140,762,758...140,824,441
Ensembl chr 1:140,762,758...140,824,441
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ACVRL1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
|
|
G |
Ada |
adenosine deaminase |
increases expression |
ISO |
tamibarotene results in increased expression of ADA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
increases expression |
ISO |
tamibarotene results in increased expression of ADGRE1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:9,431,888...9,585,883
Ensembl chr 9:9,431,860...9,585,865
|
|
G |
Adnp2 |
ADNP homeobox 2 |
affects expression |
ISO |
tamibarotene affects the expression of ADNP2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:76,637,415...76,661,186
Ensembl chr18:76,637,785...76,653,056
|
|
G |
Adora3 |
adenosine A3 receptor |
affects expression |
ISO |
tamibarotene affects the expression of ADORA3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:208,336,909...208,379,217
Ensembl chr 2:208,373,154...208,376,803
|
|
G |
Agps |
alkylglycerone phosphate synthase |
affects expression |
ISO |
tamibarotene affects the expression of AGPS mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:62,648,352...62,749,250
Ensembl chr 3:62,648,447...62,749,153
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
tamibarotene inhibits the reaction [AGT protein results in increased expression of IL6 mRNA]; tamibarotene inhibits the reaction [AGT protein results in increased secretion of IL6 protein] |
CTD |
PMID:16484594 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Ahnak |
AHNAK nucleoprotein |
decreases expression |
ISO |
tamibarotene results in decreased expression of AHNAK mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
increases expression |
ISO |
tamibarotene results in increased expression of AIF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:5,161,350...5,167,176
Ensembl chr20:5,161,333...5,166,448
|
|
G |
Ak4 |
adenylate kinase 4 |
decreases expression |
ISO |
tamibarotene results in decreased expression of AK4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:120,250,318...120,309,153
Ensembl chr 5:120,250,616...120,305,897
|
|
G |
Akap2 |
A-kinase anchoring protein 2 |
affects expression |
ISO |
tamibarotene affects the expression of PALM2AKAP2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:74,874,245...74,985,789
Ensembl chr 5:74,874,306...74,982,401
|
|
G |
Akap9 |
A-kinase anchoring protein 9 |
decreases expression |
ISO |
tamibarotene results in decreased expression of AKAP9 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:27,195,346...27,331,582
Ensembl chr 4:27,195,346...27,331,582
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of ALAS1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
affects expression |
ISO |
tamibarotene affects the expression of ALDH1B1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358
|
|
G |
Alms1 |
ALMS1, centrosome and basal body associated protein |
decreases expression |
ISO |
tamibarotene results in decreased expression of ALMS1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:117,371,544...117,472,310
Ensembl chr 4:117,371,659...117,472,198
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
increases expression |
ISO |
tamibarotene results in increased expression of ALOX5AP mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:6,854,930...6,879,112
Ensembl chr12:6,854,920...6,879,154
|
|
G |
Amd1 |
adenosylmethionine decarboxylase 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of AMD1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:45,384,000...45,399,694
Ensembl chr20:45,384,000...45,399,694
|
|
G |
Ankrd17 |
ankyrin repeat domain 17 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ANKRD17 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:19,291,025...19,431,521
Ensembl chr14:19,318,565...19,431,515
|
|
G |
Anxa2 |
annexin A2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ANXA2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:75,687,134...75,723,589
Ensembl chr 8:75,687,100...75,723,594
|
|
G |
Ap1s2 |
adaptor related protein complex 1 subunit sigma 2 |
increases expression |
ISO |
tamibarotene results in increased expression of AP1S2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:32,329,883...32,376,301
Ensembl chr X:32,329,598...32,355,307
|
|
G |
Apbb3 |
amyloid beta precursor protein binding family B member 3 |
affects expression |
ISO |
tamibarotene affects the expression of APBB3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:29,497,865...29,504,995
Ensembl chr18:29,497,863...29,504,995
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
decreases expression |
ISO |
tamibarotene results in decreased expression of APC mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531
|
|
G |
Aqp7 |
aquaporin 7 |
affects expression |
ISO |
tamibarotene affects the expression of AQP7 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:57,358,297...57,372,332
Ensembl chr 5:57,358,327...57,372,239
|
|
G |
Arf6 |
ADP-ribosylation factor 6 |
affects expression |
ISO |
tamibarotene affects the expression of ARF6 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:91,697,109...91,698,257
Ensembl chr 6:91,697,109...91,698,255
|
|
G |
Arhgap4 |
Rho GTPase activating protein 4 |
increases expression |
ISO |
tamibarotene results in increased expression of ARHGAP4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:156,873,094...156,888,762
Ensembl chr X:156,873,849...156,888,761
|
|
G |
Arhgap45 |
Rho GTPase activating protein 45 |
increases expression |
ISO |
tamibarotene results in increased expression of ARHGAP45 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:12,541,032...12,741,314
Ensembl chr 7:12,541,061...12,741,296
|
|
G |
Arhgap8 |
Rho GTPase activating protein 8 |
increases expression |
ISO |
tamibarotene results in increased expression of ARHGAP8 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 7:125,732,300...125,797,149
Ensembl chr 7:125,731,275...125,795,980
|
|
G |
Arl4c |
ADP ribosylation factor like GTPase 4C |
decreases expression |
ISO |
tamibarotene results in decreased expression of ARL4C mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:95,783,651...95,787,092
Ensembl chr 9:95,786,508...95,787,094
|
|
G |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
increases expression |
ISO |
tamibarotene results in increased expression of ASB2 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 6:127,212,325...127,248,451
Ensembl chr 6:127,212,273...127,248,372
|
|
G |
Atp13a3 |
ATPase 13A3 |
affects expression |
ISO |
tamibarotene affects the expression of ATP13A3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:73,936,750...73,963,852
Ensembl chr11:73,936,750...73,963,852
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
affects expression |
ISO |
tamibarotene affects the expression of ATP1A3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:81,852,423...81,881,565
Ensembl chr 1:81,852,429...81,881,549
|
|
G |
Atp2b1 |
ATPase plasma membrane Ca2+ transporting 1 |
affects expression |
ISO |
tamibarotene affects the expression of ATP2B1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:41,114,606...41,223,138
Ensembl chr 7:41,114,697...41,220,579
|
|
G |
Atp6v0a1 |
ATPase H+ transporting V0 subunit a1 |
increases expression |
ISO |
tamibarotene results in increased expression of ATP6V0A1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:88,914,264...88,967,736
Ensembl chr10:88,914,276...88,967,748
|
|
G |
Atp6v0a2 |
ATPase H+ transporting V0 subunit a2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ATP6V0A2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:37,368,321...37,398,233
Ensembl chr12:37,363,906...37,425,596
|
|
G |
Atp6v1a |
ATPase H+ transporting V1 subunit A |
affects expression |
ISO |
tamibarotene affects the expression of ATP6V1A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:61,531,386...61,584,634
Ensembl chr11:61,531,416...61,584,634
|
|
G |
Atpaf2 |
ATP synthase mitochondrial F1 complex assembly factor 2 |
affects expression |
ISO |
tamibarotene affects the expression of ATPAF2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:46,768,539...46,783,889
Ensembl chr10:46,768,539...46,783,889
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression |
ISO |
tamibarotene results in decreased expression of ATRX mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:76,820,110...76,979,155
Ensembl chr X:76,692,970...76,708,878 Ensembl chr X:76,692,970...76,708,878
|
|
G |
Atxn7l3b |
ataxin 7-like 3B |
affects expression |
ISO |
tamibarotene affects the expression of ATXN7L3B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:55,600,879...55,604,403
Ensembl chr 7:55,600,889...55,604,403
|
|
G |
Axin1 |
axin 1 |
increases expression |
ISO |
tamibarotene results in increased expression of AXIN1 mRNA |
CTD |
PMID:15498508 |
|
|
|
G |
Azin1 |
antizyme inhibitor 1 |
affects expression |
ISO |
tamibarotene affects the expression of AZIN1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:77,345,646...77,372,398
Ensembl chr 7:77,345,646...77,372,398
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
tamibarotene results in increased expression of BAK1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
affects expression |
ISO |
tamibarotene affects the expression of BCAT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:179,259,305...179,340,021
Ensembl chr 4:179,259,308...179,339,795
|
|
G |
Bcl11a |
BAF chromatin remodeling complex subunit BCL11A |
decreases expression |
ISO |
tamibarotene results in decreased expression of BCL11A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:108,826,717...108,921,197
Ensembl chr14:108,826,831...108,921,669
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression affects expression |
ISO |
Triiodothyronine promotes the reaction [tamibarotene results in decreased expression of BCL2 mRNA] tamibarotene affects the expression of BCL2 mRNA |
CTD |
PMID:11201846 PMID:15498508 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression multiple interactions |
ISO |
tamibarotene results in increased expression of BCL2A1 mRNA; tamibarotene results in increased expression of BCL2A1A mRNA Triiodothyronine promotes the reaction [tamibarotene results in increased expression of BCL2A1A mRNA] |
CTD |
PMID:11201846 PMID:15498508 |
|
NCBI chr 8:96,551,424...96,559,527
Ensembl chr 8:96,551,245...96,559,483
|
|
G |
Bcl7a |
BAF chromatin remodeling complex subunit BCL7A |
decreases expression |
ISO |
tamibarotene results in decreased expression of BCL7A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:38,659,294...38,691,191
Ensembl chr12:38,662,303...38,691,075
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of BCLAF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:15,799,753...15,828,838
Ensembl chr 1:15,782,477...15,860,624
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions increases expression |
ISO EXP |
[tamibarotene co-treated with BDNF] results in increased expression of NTRK2 BDNF affects the reaction [tamibarotene results in increased phosphorylation of MAPK1 protein]; BDNF affects the reaction [tamibarotene results in increased phosphorylation of MAPK3 protein]; BDNF affects the reaction [tamibarotene results in increased phosphorylation of NTRK2 protein] tamibarotene results in increased expression of BDNF mRNA |
CTD |
PMID:19182380 PMID:19457078 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
affects expression |
ISO |
tamibarotene affects the expression of BHLHE40 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:140,703,619...140,709,319
Ensembl chr 4:140,703,619...140,709,319
|
|
G |
Blmh |
bleomycin hydrolase |
decreases expression |
ISO |
tamibarotene results in decreased expression of BLMH mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:63,197,367...63,240,447
Ensembl chr10:63,197,364...63,240,332
|
|
G |
Bpi |
bactericidal/permeability-increasing protein |
increases expression |
ISO |
tamibarotene results in increased expression of BPI mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:154,741,627...154,768,584
Ensembl chr 3:154,741,631...154,768,640
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
affects expression |
ISO |
tamibarotene affects the expression of BPTF mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:95,248,573...95,350,162
Ensembl chr10:95,250,294...95,349,789
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
decreases expression |
ISO |
tamibarotene results in decreased expression of BRCA1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:89,394,821...89,455,093
Ensembl chr10:89,394,803...89,454,681
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
affects expression decreases expression |
ISO |
tamibarotene affects the expression of BRCA2 mRNA tamibarotene results in decreased expression of BRCA2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:503,660...544,754
Ensembl chr12:504,007...544,748
|
|
G |
Brd3 |
bromodomain containing 3 |
affects expression |
ISO |
tamibarotene affects the expression of BRD3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:5,995,204...6,054,467
Ensembl chr 3:5,997,315...6,054,483
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
affects expression |
ISO |
tamibarotene affects the expression of BST2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
|
|
G |
Btf3 |
basic transcription factor 3 |
affects expression |
ISO |
tamibarotene affects the expression of BTF3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:28,417,316...28,424,436
Ensembl chr 2:28,417,579...28,423,762
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
tamibarotene results in increased expression of BTG2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
increases expression |
ISO |
tamibarotene results in increased expression of CADM1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:51,858,906...52,200,591
Ensembl chr 8:52,127,399...52,189,722
|
|
G |
Camk1 |
calcium/calmodulin-dependent protein kinase I |
increases expression |
ISO |
tamibarotene results in increased expression of CAMK1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:145,289,300...145,300,146
Ensembl chr 4:145,288,996...145,300,177
|
|
G |
Camta2 |
calmodulin binding transcription activator 2 |
increases expression |
ISO |
tamibarotene results in increased expression of CAMTA2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:57,291,192...57,309,638
Ensembl chr10:57,291,192...57,309,298
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
tamibarotene results in increased expression of CAPG mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Caprin1 |
cell cycle associated protein 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CAPRIN1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:93,701,830...93,789,580
Ensembl chr 3:93,702,487...93,789,617
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
tamibarotene results in increased expression of CASP9 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cbx3 |
chromobox 3 |
affects expression |
ISO |
tamibarotene affects the expression of CBX3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:81,243,809...81,257,898
Ensembl chr 4:81,244,469...81,257,897
|
|
G |
Ccdc22 |
coiled-coil domain containing 22 |
affects expression |
ISO |
tamibarotene affects the expression of CCDC22 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:15,742,978...15,754,925
Ensembl chr X:15,742,978...15,754,925
|
|
G |
Ccdc93 |
coiled-coil domain containing 93 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CCDC93 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:37,400,455...37,473,973
Ensembl chr13:37,400,476...37,468,840
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
ISO |
tamibarotene results in increased expression of CCL4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression decreases expression |
ISO |
tamibarotene results in increased expression of CCL5 mRNA tamibarotene results in decreased expression of CCL5 mRNA |
CTD |
PMID:15498508 PMID:20861477 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccl6 |
C-C motif chemokine ligand 6 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CCL6 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
ISO |
tamibarotene results in increased expression of CCND1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnf |
cyclin F |
decreases expression |
ISO |
tamibarotene results in decreased expression of CCNF mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:13,594,687...13,619,935
Ensembl chr10:13,594,687...13,619,935
|
|
G |
Ccng1 |
cyclin G1 |
affects expression |
ISO |
tamibarotene affects the expression of CCNG1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:25,903,925...25,910,298
Ensembl chr10:25,903,911...25,910,325
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
increases expression |
ISO |
tamibarotene results in increased expression of CCR1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:132,996,646...133,002,201
Ensembl chr 8:132,996,649...133,002,201
|
|
G |
Cd22 |
CD22 molecule |
affects expression |
ISO |
tamibarotene affects the expression of CD22 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:89,313,475...89,329,902
Ensembl chr 1:89,314,558...89,329,418
|
|
G |
Cd300a |
Cd300a molecule |
increases expression |
ISO |
tamibarotene results in increased expression of CD300A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:103,437,978...103,451,170
Ensembl chr10:103,438,303...103,450,947
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
tamibarotene promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA] tamibarotene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CD36 mRNA] |
CTD |
PMID:16484594 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd38 |
CD38 molecule |
increases expression |
ISO |
tamibarotene results in increased expression of CD38 mRNA; tamibarotene results in increased expression of CD38 protein |
CTD |
PMID:15498508 PMID:21393419 |
|
NCBI chr14:71,714,768...71,754,990
Ensembl chr14:71,715,269...71,754,672
|
|
G |
Cd3d |
CD3d molecule |
decreases expression |
ISO |
tamibarotene results in decreased expression of CD3D mRNA |
CTD |
PMID:20861477 |
|
NCBI chr 8:49,282,502...49,287,095
Ensembl chr 8:49,282,460...49,287,110
|
|
G |
Cd3g |
CD3g molecule |
decreases expression |
ISO |
tamibarotene results in decreased expression of CD3G mRNA |
CTD |
PMID:20861477 |
|
NCBI chr 8:49,274,553...49,280,943
Ensembl chr 8:49,274,960...49,280,901
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
decreases expression affects expression |
ISO |
tamibarotene results in decreased expression of CD44 mRNA tamibarotene affects the expression of CD44 mRNA |
CTD |
PMID:15498508 PMID:17229644 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd53 |
Cd53 molecule |
increases expression |
ISO |
tamibarotene results in increased expression of CD53 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:209,489,279...209,537,098
Ensembl chr 2:209,489,279...209,537,087
|
|
G |
Cd68 |
Cd68 molecule |
decreases expression |
ISO |
tamibarotene results in decreased expression of CD68 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Cd69 |
Cd69 molecule |
affects expression |
ISO |
tamibarotene affects the expression of CD69 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:163,041,147...163,049,065
Ensembl chr 4:163,041,141...163,049,084
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
ISO |
tamibarotene results in increased expression of CD74 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849
|
|
G |
Cd79a |
CD79a molecule |
increases expression |
ISO |
tamibarotene results in increased expression of CD79A mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 1:81,763,609...81,768,039
Ensembl chr 1:81,763,614...81,767,980
|
|
G |
Cdc25a |
cell division cycle 25A |
decreases expression |
ISO |
tamibarotene results in decreased expression of CDC25A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:117,953,223...117,971,552
Ensembl chr 8:117,953,444...117,971,519
|
|
G |
Cdc6 |
cell division cycle 6 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CDC6 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
affects expression |
ISO |
tamibarotene affects the expression of CDK10 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:56,024,903...56,032,610
Ensembl chr19:56,024,903...56,032,605
|
|
G |
Cdk8 |
cyclin-dependent kinase 8 |
affects expression |
ISO |
tamibarotene affects the expression of CDK8 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:10,496,273...10,561,335
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
tamibarotene results in increased expression of CDKN1A mRNA |
CTD |
PMID:17229644 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Ceacam6 |
CEA cell adhesion molecule 6 |
increases expression multiple interactions |
ISO |
tamibarotene results in increased expression of CEACAM6 mRNA CSF3 protein promotes the reaction [tamibarotene results in increased expression of CEACAM6 mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in decreased expression of CEACAM6 mRNA]; tamibarotene promotes the reaction [CSF3 protein results in increased expression of CEACAM6 mRNA] |
CTD |
PMID:27737899 |
|
NCBI chr 1:81,683,500...81,701,230
Ensembl chr 1:81,683,463...81,701,317
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression |
ISO |
tamibarotene results in increased expression of CEBPB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
increases expression |
ISO |
tamibarotene results in increased expression of CEBPD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
increases expression multiple interactions |
ISO |
tamibarotene results in increased expression of CEBPE mRNA CSF3 protein promotes the reaction [tamibarotene results in increased expression of CEBPE mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in decreased expression of CEBPE mRNA]; tamibarotene promotes the reaction [CSF3 protein results in increased expression of CEBPE mRNA] |
CTD |
PMID:27737899 |
|
NCBI chr15:33,356,119...33,357,517
Ensembl chr15:33,355,947...33,358,138
|
|
G |
Cebpg |
CCAAT/enhancer binding protein gamma |
decreases expression |
ISO |
tamibarotene results in decreased expression of CEBPG mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:91,286,956...91,297,459
Ensembl chr 1:91,287,917...91,296,656
|
|
G |
Celf1 |
CUGBP, Elav-like family member 1 |
affects expression |
ISO |
tamibarotene affects the expression of CELF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:79,768,900...79,844,548
Ensembl chr 3:79,823,945...79,842,082
|
|
G |
Cep135 |
centrosomal protein 135 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CEP135 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:34,052,168...34,115,763
Ensembl chr14:34,051,003...34,115,273
|
|
G |
Chka |
choline kinase alpha |
decreases expression |
ISO |
tamibarotene results in decreased expression of CHKA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:219,076,618...219,126,221
Ensembl chr 1:219,077,771...219,126,220
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
increases expression |
ISO |
tamibarotene results in increased expression of CIITA mRNA |
CTD |
PMID:17229644 |
|
NCBI chr10:5,212,621...5,260,641
Ensembl chr10:5,213,350...5,260,608
|
|
G |
Clcnka |
chloride voltage-gated channel Ka |
decreases expression |
ISO |
tamibarotene results in decreased expression of CLCNKA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:159,931,497...159,946,483
Ensembl chr 5:159,931,511...159,946,446
|
|
G |
Cltb |
clathrin, light chain B |
increases expression |
ISO |
tamibarotene results in increased expression of CLTB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:10,537,348...10,554,999
Ensembl chr17:10,537,365...10,554,989
|
|
G |
Col11a2 |
collagen type XI alpha 2 chain |
affects expression |
ISO |
tamibarotene affects the expression of COL11A2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:3,829,324...3,859,022
Ensembl chr20:3,830,164...3,859,018
|
|
G |
Coro1a |
coronin 1A |
increases expression |
ISO |
tamibarotene results in increased expression of CORO1A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:198,123,883...198,128,890
Ensembl chr 1:198,123,884...198,128,857
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
affects expression |
ISO |
tamibarotene affects the expression of CREB1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
|
|
G |
Creb3 |
cAMP responsive element binding protein 3 |
increases expression |
ISO |
tamibarotene results in increased expression of CREB3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:59,063,532...59,068,196
Ensembl chr 5:59,063,531...59,068,188
|
|
G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
increases expression |
ISO |
tamibarotene results in increased expression of CREG1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:83,972,186...83,984,675
Ensembl chr13:83,972,212...83,984,675
|
|
G |
Csf3 |
colony stimulating factor 3 |
multiple interactions |
ISO |
[tamibarotene co-treated with CSF3 protein] results in increased expression of CEACAM8 mRNA; CSF3 protein inhibits the reaction [tamibarotene results in decreased expression of ITGB2 mRNA]; CSF3 protein inhibits the reaction [tamibarotene results in increased expression of ITGAM mRNA]; CSF3 protein promotes the reaction [tamibarotene results in increased expression of CEACAM6 mRNA]; CSF3 protein promotes the reaction [tamibarotene results in increased expression of CEBPE mRNA]; CSF3 protein promotes the reaction [tamibarotene results in increased expression of RARB mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in decreased expression of CEACAM6 mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in decreased expression of CEBPE mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in increased expression of ITGB2 mRNA]; tamibarotene promotes the reaction [CSF3 protein results in increased expression of CEACAM6 mRNA]; tamibarotene promotes the reaction [CSF3 protein results in increased expression of CEBPE mRNA]; tamibarotene promotes the reaction [CSF3 protein results in increased expression of RARB mRNA] |
CTD |
PMID:27737899 |
|
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
affects expression |
ISO |
tamibarotene affects the expression of CSRP1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:52,553,843...52,575,054
Ensembl chr13:52,553,775...52,575,051
|
|
G |
Cst3 |
cystatin C |
increases expression |
ISO |
tamibarotene results in increased expression of CST3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:143,219,671...143,223,544
Ensembl chr 3:143,219,686...143,223,615
|
|
G |
Ctif |
cap binding complex dependent translation initiation factor |
decreases expression |
ISO |
tamibarotene results in decreased expression of CTIF mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:71,467,381...71,701,423
Ensembl chr18:71,463,486...71,829,881
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CTNNAL1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:73,561,249...73,621,070
Ensembl chr 5:73,561,450...73,621,070
|
|
G |
Ctsa |
cathepsin A |
increases expression |
ISO |
tamibarotene results in increased expression of CTSA mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 3:161,298,750...161,304,627
Ensembl chr 3:161,298,962...161,304,625
|
|
G |
Ctsd |
cathepsin D |
increases expression |
ISO |
tamibarotene results in increased expression of CTSD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
|
|
G |
Cul1 |
cullin 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CUL1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:77,211,814...77,283,369
Ensembl chr 4:77,211,692...77,280,250
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CXCL10 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
decreases expression |
ISO |
tamibarotene results in decreased expression of CXCL9 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions decreases expression |
ISO |
tamibarotene results in increased uptake of and affects the localization of CXCR4 protein tamibarotene results in decreased expression of CXCR4 mRNA |
CTD |
PMID:20141446 PMID:20861477 |
|
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cxcr5 |
C-X-C motif chemokine receptor 5 |
increases expression |
ISO |
tamibarotene results in increased expression of CXCR5 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:48,835,688...48,852,032
Ensembl chr 8:48,836,957...48,850,671
|
|
G |
Cyba |
cytochrome b-245 alpha chain |
increases expression |
ISO |
tamibarotene results in increased expression of CYBA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876
|
|
G |
Cybb |
cytochrome b-245 beta chain |
increases expression |
ISO |
tamibarotene results in increased expression of CYBB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:14,578,330...14,610,049
Ensembl chr X:14,578,264...14,612,547
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
tamibarotene inhibits the reaction [Calcitriol results in increased expression of CYP24A1 mRNA] |
CTD |
PMID:16289102 |
|
NCBI chr 3:168,097,484...168,111,920
Ensembl chr 3:168,097,485...168,111,920
|
|
G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of DAAM1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:94,606,675...94,739,026
Ensembl chr 6:94,636,222...94,739,026
|
|
G |
Dagla |
diacylglycerol lipase, alpha |
affects expression |
ISO |
tamibarotene affects the expression of DAGLA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:226,297,013...226,353,712
Ensembl chr 1:226,297,016...226,353,611
|
|
G |
Dapk2 |
death-associated protein kinase 2 |
increases expression |
ISO |
tamibarotene results in increased expression of DAPK2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:71,822,107...71,941,941
Ensembl chr 8:71,822,129...71,941,910
|
|
G |
Ddx18 |
DEAD-box helicase 18 |
affects expression |
ISO |
tamibarotene affects the expression of DDX18 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:37,522,558...37,536,066
Ensembl chr13:37,522,561...37,536,066
|
|
G |
Ddx21 |
DExD-box helicase 21 |
decreases expression |
ISO |
tamibarotene results in decreased expression of DDX21 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:32,213,147...32,232,632
Ensembl chr20:32,213,148...32,232,632
|
|
G |
Ddx51 |
DEAD-box helicase 51 |
affects expression |
ISO |
tamibarotene affects the expression of DDX51 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:52,067,183...52,072,249
Ensembl chr12:52,067,183...52,072,108
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
ISO |
tamibarotene results in increased expression of DHRS3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
|
|
G |
Dmbt1 |
deleted in malignant brain tumors 1 |
affects expression |
ISO |
tamibarotene affects the expression of DMBT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:201,620,642...201,689,905 NCBI chr 1:203,149,414...203,228,705
|
|
G |
Dok2 |
docking protein 2 |
increases expression |
ISO |
tamibarotene results in increased expression of DOK2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:52,449,884...52,455,414
Ensembl chr15:52,451,161...52,456,409
|
|
G |
Dph1 |
diphthamide biosynthesis 1 |
increases expression |
ISO |
tamibarotene results in increased expression of DPH1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:62,019,379...62,032,384
Ensembl chr10:62,019,379...62,032,407
|
|
G |
Dst |
dystonin |
decreases expression |
ISO |
tamibarotene results in decreased expression of DST mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:37,902,336...38,296,961
Ensembl chr 9:37,902,303...38,196,273
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
decreases expression |
ISO |
tamibarotene results in decreased expression of DUSP10 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr13:104,284,660...104,321,455
Ensembl chr13:104,284,660...104,321,455
|
|
G |
Dvl1 |
dishevelled segment polarity protein 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of DVL1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:173,295,948...173,308,014
Ensembl chr 5:173,296,270...173,307,945
|
|
G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of DYNC1LI2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:740,007...762,897
Ensembl chr19:740,028...762,897
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
affects expression |
ISO |
tamibarotene affects the expression of ECI1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:13,797,573...13,810,918
Ensembl chr10:13,797,562...13,810,913
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
tamibarotene results in increased expression of EDN1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Edn2 |
endothelin 2 |
increases expression |
ISO |
tamibarotene results in increased expression of EDN2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:139,098,472...139,106,396
Ensembl chr 5:139,100,898...139,105,792
|
|
G |
Edrf1 |
erythroid differentiation regulatory factor 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of EDRF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:205,706,023...205,743,676
Ensembl chr 1:205,706,468...205,743,653
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
increases expression |
ISO |
tamibarotene results in increased expression of EEF1A1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:85,838,594...85,841,816
Ensembl chr 8:85,838,869...85,840,818
|
|
G |
Eef1e1 |
eukaryotic translation elongation factor 1 epsilon 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of EEF1E1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:26,785,017...26,795,723
Ensembl chr17:26,785,029...26,797,161
|
|
G |
Egr3 |
early growth response 3 |
increases expression |
ISO |
tamibarotene results in increased expression of EGR3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:51,756,683...51,762,080
Ensembl chr15:51,756,736...51,760,722
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
affects expression |
ISO |
tamibarotene affects the expression of EIF2A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:148,722,343...148,755,781
Ensembl chr 2:148,722,231...148,755,520
|
|
G |
Eif2s3 |
eukaryotic translation initiation factor 2 subunit gamma |
affects expression |
ISO |
tamibarotene affects the expression of EIF2S3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:63,268,106...63,291,125
Ensembl chr X:63,268,037...63,292,092
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
decreases expression |
ISO |
tamibarotene results in decreased expression of EIF3A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:282,139,809...282,170,017
Ensembl chr 1:282,139,823...282,170,017
|
|
G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of EIF4A2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:81,373,047...81,379,680
Ensembl chr11:81,373,048...81,379,871
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
decreases expression |
ISO |
tamibarotene results in decreased expression of EIF4B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:143,679,656...143,701,452
Ensembl chr 7:143,679,617...143,701,452
|
|
G |
Epx |
eosinophil peroxidase |
decreases expression |
ISO |
tamibarotene results in decreased expression of EPX mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:75,160,690...75,171,774
Ensembl chr10:75,160,690...75,171,774
|
|
G |
Ercc8 |
ERCC excision repair 8, CSA ubiquitin ligase complex subunit |
decreases expression |
ISO |
tamibarotene results in decreased expression of ERCC8 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:39,434,617...39,473,392
Ensembl chr 2:39,434,634...39,472,017
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity |
ISO |
tamibarotene results in increased activity of ESR1 protein |
CTD |
PMID:25257666 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Evx1 |
even-skipped homeobox 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of EVX1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:82,370,829...82,374,313
Ensembl chr 4:82,370,997...82,375,374
|
|
G |
Exoc3 |
exocyst complex component 3 |
affects expression |
ISO |
tamibarotene affects the expression of EXOC3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:31,700,953...31,731,726
Ensembl chr 1:31,700,953...31,731,815
|
|
G |
F3 |
coagulation factor III, tissue factor |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in decreased expression of F3 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in decreased expression of F3 mRNA] |
CTD |
PMID:15020266 |
|
NCBI chr 2:225,310,686...225,322,281
Ensembl chr 2:225,310,624...225,322,272
|
|
G |
Fam89b |
family with sequence similarity 89, member B |
increases expression |
ISO |
tamibarotene results in increased expression of FAM89B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:221,085,894...221,087,449
Ensembl chr 1:221,085,895...221,087,449
|
|
G |
Fas |
Fas cell surface death receptor |
increases activity |
ISO |
tamibarotene results in increased activity of FAS protein |
CTD |
PMID:15703382 |
|
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
affects expression |
ISO |
tamibarotene affects the expression of FAT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr16:50,372,150...50,501,716
Ensembl chr16:50,372,128...50,501,921
|
|
G |
Fbn2 |
fibrillin 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of FBN2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:53,068,495...53,272,254
Ensembl chr18:53,068,495...53,181,503
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of FBP1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:396,175...417,480
Ensembl chr17:396,180...417,480
|
|
G |
Fcer1g |
Fc fragment of IgE receptor Ig |
increases expression |
ISO |
tamibarotene results in increased expression of FCER1G mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:89,601,894...89,606,326
Ensembl chr13:89,601,896...89,606,326
|
|
G |
Fcgr1a |
Fc fragment of IgG receptor Ia |
affects expression |
ISO |
tamibarotene affects the expression of FCGR1A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:198,430,536...198,439,453
Ensembl chr 2:198,430,530...198,458,041
|
|
G |
Fcgr2b |
Fc fragment of IgG receptor IIb |
affects expression |
ISO |
tamibarotene affects the expression of FCGR2B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
affects expression |
ISO |
tamibarotene affects the expression of FES mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:142,174,648...142,183,884
Ensembl chr 1:142,174,648...142,183,884
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of FGFR1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Fgr |
FGR proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
tamibarotene results in increased expression of FGR mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:151,172,189...151,199,746
Ensembl chr 5:151,172,206...151,199,745
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
decreases expression |
ISO |
tamibarotene results in decreased expression of FKBP5 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
|
|
G |
Flot1 |
flotillin 1 |
increases expression |
ISO |
tamibarotene results in increased expression of FLOT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:3,427,890...3,438,418
Ensembl chr20:3,427,880...3,438,396
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
tamibarotene results in increased expression of FOSB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
|
|
G |
Foxo4 |
forkhead box O4 |
increases expression |
ISO |
tamibarotene results in increased expression of FOXO4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:71,155,284...71,162,158
Ensembl chr X:71,155,601...71,162,158
|
|
G |
Foxp3 |
forkhead box P3 |
decreases expression |
ISO |
tamibarotene results in decreased expression of FOXP3 mRNA |
CTD |
PMID:22077062 |
|
NCBI chr X:15,753,175...15,768,648
Ensembl chr X:15,753,175...15,768,522
|
|
G |
Fuca1 |
alpha-L-fucosidase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of FUCA1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:154,269,296...154,286,545
Ensembl chr 5:154,269,118...154,286,544
|
|
G |
Fut4 |
fucosyltransferase 4 |
increases expression |
ISO |
tamibarotene results in increased expression of FUT4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:13,258,768...13,262,729
Ensembl chr 8:13,258,768...13,262,729
|
|
G |
Fyb1 |
FYN binding protein 1 |
affects expression |
ISO |
tamibarotene affects the expression of FYB1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:55,834,904...55,983,805
Ensembl chr 2:55,835,151...55,983,804
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
decreases expression |
ISO |
tamibarotene results in decreased expression of FYN mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
decreases expression |
ISO |
tamibarotene results in decreased expression of GADD45A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Galk2 |
galactokinase 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of GALK2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:118,137,097...118,268,838
Ensembl chr 3:118,136,838...118,268,836
|
|
G |
Galt |
galactose-1-phosphate uridylyltransferase |
increases expression |
ISO |
tamibarotene results in increased expression of GALT mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:58,144,679...58,147,946
Ensembl chr 5:58,144,705...58,147,929
|
|
G |
Gata2 |
GATA binding protein 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of GATA2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488
|
|
G |
Gatad1 |
GATA zinc finger domain containing 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of GATAD1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:27,647,005...27,658,533
Ensembl chr 4:27,647,335...27,657,167
|
|
G |
Gatc |
glutamyl-tRNA amidotransferase subunit C |
affects expression |
ISO |
tamibarotene affects the expression of GATC mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:47,031,545...47,039,556
Ensembl chr12:46,989,951...47,039,542 Ensembl chr12:46,989,951...47,039,542
|
|
G |
Gca |
grancalcin |
increases expression |
ISO |
tamibarotene results in increased expression of GCA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:48,625,965...48,661,317
Ensembl chr 3:48,626,038...48,661,317
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
tamibarotene results in increased expression of GFAP |
CTD |
PMID:19182380 |
|
NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
affects expression |
ISO |
tamibarotene affects the expression of GFPT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:118,852,046...118,901,583
Ensembl chr 4:118,852,062...118,901,591
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of GGT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:14,019,723...14,045,781
Ensembl chr20:14,019,723...14,025,068
|
|
G |
Glod4 |
glyoxalase domain containing 4 |
affects expression |
ISO |
tamibarotene affects the expression of GLOD4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:64,379,922...64,398,263
Ensembl chr10:64,379,921...64,398,294
|
|
G |
Glrx |
glutaredoxin |
increases expression |
ISO |
tamibarotene results in increased expression of GLRX mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
|
|
G |
Gnaq |
G protein subunit alpha q |
affects expression |
ISO |
tamibarotene affects the expression of GNAQ mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:233,382,778...233,622,584
Ensembl chr 1:233,382,708...233,622,786
|
|
G |
Gng4 |
G protein subunit gamma 4 |
decreases expression |
ISO |
tamibarotene results in decreased expression of GNG4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:90,266,571...90,316,278
Ensembl chr17:90,266,794...90,315,492
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
affects expression |
ISO |
tamibarotene affects the expression of GPX1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
increases expression affects expression |
ISO |
tamibarotene results in increased expression of GRINA mRNA tamibarotene affects the expression of GRINA mRNA |
CTD |
PMID:15498508 PMID:17229644 |
|
NCBI chr 7:117,304,742...117,307,916
Ensembl chr 7:117,304,742...117,307,916
|
|
G |
Grn |
granulin precursor |
increases expression |
ISO |
tamibarotene results in increased expression of GRN mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:90,377,103...90,383,207
Ensembl chr10:90,376,933...90,383,205
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
affects expression |
ISO |
tamibarotene affects the expression of GSK3B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:65,060,884...65,208,842
Ensembl chr11:65,066,235...65,209,268
|
|
G |
Gsn |
gelsolin |
increases expression |
ISO |
tamibarotene results in increased expression of GSN mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
tamibarotene results in increased expression of GSTM1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
increases expression |
ISO |
tamibarotene results in increased expression of GSTO1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
H4c3 |
H4 clustered histone 3 |
affects expression |
ISO |
tamibarotene affects the expression of H4C3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:170,144,871...170,145,311
Ensembl chr 4:170,144,951...170,145,262
|
|
G |
H4f3 |
H1.3 linker histone, cluster member |
affects expression |
ISO |
tamibarotene affects the expression of H1-3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:43,797,711...43,798,450
Ensembl chr17:43,797,721...43,798,383
|
|
G |
Hck |
HCK proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
tamibarotene results in increased expression of HCK mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:148,579,917...148,623,026
Ensembl chr 3:148,579,920...148,623,033
|
|
G |
Hipk1 |
homeodomain interacting protein kinase 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of HIPK1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:206,224,015...206,274,910
Ensembl chr 2:206,224,015...206,274,079
|
|
G |
Hira |
histone cell cycle regulator |
affects expression |
ISO |
tamibarotene affects the expression of HIRA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:86,168,196...86,276,430
Ensembl chr11:86,168,196...86,276,430
|
|
G |
Hist2h2aa3 |
histone cluster 2 H2A family member A3 |
increases expression |
ISO |
tamibarotene results in increased expression of H2AC18 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:198,388,766...198,389,293
Ensembl chr 2:198,388,809...198,389,201 Ensembl chr 2:198,388,809...198,389,201
|
|
G |
Hk3 |
hexokinase 3 |
increases expression |
ISO |
tamibarotene results in increased expression of HK3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr17:10,134,726...10,152,976
Ensembl chr17:10,137,974...10,152,956
|
|
G |
Hlx |
H2.0-like homeobox |
affects expression |
ISO |
tamibarotene affects the expression of HLX mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:102,637,967...102,643,376
Ensembl chr13:102,637,769...102,643,223
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
affects expression |
ISO |
tamibarotene affects the expression of HMGCS1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
|
|
G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
increases expression |
ISO |
tamibarotene results in increased expression of HPD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:38,828,606...38,839,956
Ensembl chr12:38,828,444...38,839,969
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
affects expression |
ISO |
tamibarotene affects the expression of HPGD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr16:37,457,134...37,495,758
Ensembl chr16:37,457,135...37,495,758
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
affects expression |
ISO |
tamibarotene affects the expression of HSP90AB1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:17,817,791...17,823,163
Ensembl chr 9:17,817,721...17,823,243
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of HSP90B1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:27,226,570...27,240,533
Ensembl chr 7:27,226,569...27,240,533
|
|
G |
Ice1 |
interactor of little elongation complex ELL subunit 1 |
affects expression |
ISO |
tamibarotene affects the expression of ICE1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:35,280,481...35,322,769
Ensembl chr 1:35,280,701...35,319,182
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
ISO |
tamibarotene results in increased expression of IER3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:3,438,798...3,440,002
Ensembl chr20:3,438,798...3,440,769
|
|
G |
Ifi35 |
interferon-induced protein 35 |
increases expression |
ISO |
tamibarotene results in increased expression of IFI35 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:89,358,376...89,366,628
Ensembl chr10:89,358,376...89,366,626
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
increases expression |
ISO |
tamibarotene results in increased expression of IFIT3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:252,906,234...252,911,377
Ensembl chr 1:252,906,234...252,911,382
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression increases response to substance |
ISO EXP |
tamibarotene inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein] tamibarotene inhibits the reaction [MBP results in increased expression of IFNG mRNA] tamibarotene results in decreased expression of IFNG mRNA IFNG results in increased susceptibility to tamibarotene tamibarotene results in decreased expression of IFNG; tamibarotene results in decreased expression of IFNG protein |
CTD |
PMID:10828746 PMID:11043609 PMID:11501064 PMID:20861477 PMID:22077062 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
affects expression |
ISO |
tamibarotene affects the expression of IGFBP2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
increases expression |
ISO |
tamibarotene results in increased expression of IGFBP3 mRNA; tamibarotene results in increased expression of IGFBP3 protein |
CTD |
PMID:10766424 |
|
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
|
|
G |
Ighg1 |
immunoglobulin heavy constant gamma 1 |
affects expression |
ISO |
tamibarotene affects the expression of IGHG1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:139,140,572...139,784,388
Ensembl chr 6:139,140,679...139,142,218
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
affects expression |
ISO |
tamibarotene affects the expression of IKZF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:91,782,281...91,867,828
Ensembl chr14:91,782,354...91,867,424
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
tamibarotene inhibits the reaction [MBP results in increased expression of IL10 mRNA] |
CTD |
PMID:11501064 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il10rb |
interleukin 10 receptor subunit beta |
increases expression |
ISO |
tamibarotene results in increased expression of IL10RB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:31,560,301...31,582,457
Ensembl chr11:31,560,530...31,582,457
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
IL17A affects the reaction [tamibarotene results in decreased expression of TGFB1 mRNA] |
CTD |
PMID:22077062 |
|
NCBI chr 9:26,841,299...26,844,786
Ensembl chr 9:26,841,299...26,844,786
|
|
G |
Il17rd |
interleukin 17 receptor D |
decreases expression |
ISO |
tamibarotene results in decreased expression of IL17RD mRNA |
CTD |
PMID:20861477 |
|
NCBI chr16:2,670,471...2,737,271
Ensembl chr16:2,670,618...2,731,808
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression increases expression |
ISO |
tamibarotene inhibits the reaction [IL1B results in increased expression of IL6 mRNA]; tamibarotene inhibits the reaction [IL1B results in increased expression of IL6 protein] tamibarotene results in decreased expression of IL1B mRNA tamibarotene results in increased expression of IL1B mRNA |
CTD |
PMID:9873234 PMID:15498508 PMID:20861477 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il21 |
interleukin 21 |
multiple interactions |
ISO |
tamibarotene inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL21 protein] |
CTD |
PMID:22077062 |
|
NCBI chr 2:123,965,021...123,972,356
Ensembl chr 2:123,965,021...123,972,356
|
|
G |
Il27 |
interleukin 27 |
decreases expression |
ISO |
tamibarotene results in decreased expression of IL27 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr 1:198,003,615...198,010,112
Ensembl chr 1:198,003,683...198,008,893
|
|
G |
Il2rg |
interleukin 2 receptor subunit gamma |
decreases expression |
ISO |
tamibarotene results in decreased expression of IL2RG mRNA |
CTD |
PMID:20861477 |
|
NCBI chr X:71,165,378...71,169,078
Ensembl chr X:71,162,585...71,169,865
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP |
HX 600 promotes the reaction [tamibarotene inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased expression of IL4 protein]]; LE 540 inhibits the reaction [tamibarotene inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased expression of IL4 protein]]; tamibarotene inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased expression of IL4 mRNA]; tamibarotene inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased expression of IL4 protein] |
CTD |
PMID:11233995 |
|
NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
tamibarotene inhibits the reaction [AGT protein results in increased expression of IL6 mRNA]; tamibarotene inhibits the reaction [AGT protein results in increased secretion of IL6 protein]; tamibarotene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6]; tamibarotene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL6 mRNA]; tamibarotene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL6 protein] tamibarotene results in decreased expression of IL6 mRNA tamibarotene affects the reaction [MBP results in increased expression of IL6 mRNA] tamibarotene inhibits the reaction [IL1B results in increased expression of IL6 mRNA]; tamibarotene inhibits the reaction [IL1B results in increased expression of IL6 protein] |
CTD |
PMID:9873234 PMID:10828746 PMID:11043609 PMID:11501064 PMID:16484594 PMID:17229644 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Il6r |
interleukin 6 receptor |
decreases expression |
ISO |
tamibarotene results in decreased expression of IL6RA protein |
CTD |
PMID:20861477 |
|
NCBI chr 2:189,196,180...189,255,987
Ensembl chr 2:189,205,701...189,254,628
|
|
G |
Il7 |
interleukin 7 |
decreases expression |
ISO |
tamibarotene results in decreased expression of IL7 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr 2:96,427,884...96,474,979
Ensembl chr 2:96,439,286...96,474,977
|
|
G |
Il7r |
interleukin 7 receptor |
decreases expression |
ISO |
tamibarotene results in decreased expression of IL7R mRNA |
CTD |
PMID:20861477 |
|
|
|
G |
Ilf3 |
interleukin enhancer binding factor 3 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ILF3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:22,402,877...22,440,984
Ensembl chr 8:22,402,890...22,440,885
|
|
G |
Ilk |
integrin-linked kinase |
increases expression |
ISO |
tamibarotene results in increased expression of ILK mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:170,578,941...170,585,192
Ensembl chr 1:170,578,889...170,585,189
|
|
G |
Ipo5 |
importin 5 |
affects expression |
ISO |
tamibarotene affects the expression of IPO5 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:106,243,110...106,293,326
Ensembl chr15:106,257,650...106,292,112
|
|
G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
increases expression |
ISO |
tamibarotene results in increased expression of IRAK2 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 4:145,594,575...145,651,066
Ensembl chr 4:145,594,575...145,651,053
|
|
G |
Irf1 |
interferon regulatory factor 1 |
increases expression |
ISO |
tamibarotene results in increased expression of IRF1 mRNA |
CTD |
PMID:15498508 PMID:17229644 |
|
NCBI chr10:39,109,530...39,116,532
Ensembl chr10:39,109,522...39,116,531
|
|
G |
Irf7 |
interferon regulatory factor 7 |
increases expression |
ISO |
tamibarotene results in increased expression of IRF7 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:214,249,388...214,252,909
Ensembl chr 1:214,248,837...214,252,456
|
|
G |
Irf9 |
interferon regulatory factor 9 |
increases expression |
ISO |
tamibarotene results in increased expression of IRF9 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:34,282,936...34,288,981
Ensembl chr15:34,282,936...34,288,138
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
affects expression |
ISO |
tamibarotene affects the expression of ISG15 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:173,624,862...173,629,124
Ensembl chr 5:173,624,310...173,626,248
|
|
G |
Isg20 |
interferon stimulated exonuclease gene 20 |
affects expression |
ISO |
tamibarotene affects the expression of ISG20 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:140,602,553...140,608,892
Ensembl chr 1:140,601,791...140,608,946
|
|
G |
Itga3 |
integrin subunit alpha 3 |
increases expression |
ISO |
tamibarotene results in increased expression of ITGA3 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr10:82,855,841...82,887,755
Ensembl chr10:82,855,613...82,887,497
|
|
G |
Itga4 |
integrin subunit alpha 4 |
affects expression |
ISO |
tamibarotene affects the expression of ITGA4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:66,178,745...66,265,547
Ensembl chr 3:66,193,059...66,263,960
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression multiple interactions affects expression |
ISO |
tamibarotene results in increased expression of ITGAM mRNA; tamibarotene results in increased expression of ITGAM protein CSF3 protein inhibits the reaction [tamibarotene results in increased expression of ITGAM mRNA]; Triiodothyronine promotes the reaction [tamibarotene results in increased expression of ITGAM protein] tamibarotene affects the expression of ITGAM protein |
CTD |
PMID:11201846 PMID:15498508 PMID:21393419 PMID:27737899 |
|
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
|
|
G |
Itgb2 |
integrin subunit beta 2 |
increases expression multiple interactions decreases expression |
ISO |
tamibarotene results in increased expression of ITGB2 mRNA CSF3 protein inhibits the reaction [tamibarotene results in decreased expression of ITGB2 mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in increased expression of ITGB2 mRNA] |
CTD |
PMID:15498508 PMID:27737899 |
|
NCBI chr20:11,777,773...11,815,647
Ensembl chr20:11,777,783...11,815,647
|
|
G |
Itgb7 |
integrin subunit beta 7 |
increases expression |
ISO |
tamibarotene results in increased expression of ITGB7 mRNA |
CTD |
PMID:15498508 PMID:17229644 |
|
NCBI chr 7:143,820,236...143,837,802
Ensembl chr 7:143,820,900...143,837,780
|
|
G |
Itpr2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
affects expression |
ISO |
tamibarotene affects the expression of ITPR2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:180,423,452...180,800,088
Ensembl chr 4:180,538,389...180,722,358
|
|
G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ITPR3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:5,645,894...5,711,702
Ensembl chr20:5,646,097...5,711,702
|
|
G |
Jak1 |
Janus kinase 1 |
affects expression |
ISO |
tamibarotene affects the expression of JAK1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:119,982,503...120,091,452
Ensembl chr 5:119,982,943...120,083,904
|
|
G |
Jak3 |
Janus kinase 3 |
decreases expression |
ISO |
tamibarotene results in decreased expression of JAK3 mRNA |
CTD |
PMID:20861477 |
|
NCBI chr16:20,107,471...20,120,678
Ensembl chr16:20,109,200...20,120,668
|
|
G |
Kat5 |
lysine acetyltransferase 5 |
increases expression |
ISO |
tamibarotene results in increased expression of KAT5 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:220,967,795...220,974,596
Ensembl chr 1:220,967,796...220,974,597
|
|
G |
Kcnab2 |
potassium voltage-gated channel subfamily A regulatory beta subunit 2 |
affects expression |
ISO |
tamibarotene affects the expression of KCNAB2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:169,570,327...169,658,875
Ensembl chr 5:169,572,517...169,658,875
|
|
G |
Kdm5b |
lysine demethylase 5B |
affects expression |
ISO |
tamibarotene affects the expression of KDM5B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:51,384,371...51,455,392
Ensembl chr13:51,384,389...51,455,357
|
|
G |
Kif2a |
kinesin family member 2A |
decreases expression |
ISO |
tamibarotene results in decreased expression of KIF2A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:38,145,507...38,208,765
Ensembl chr 2:38,147,601...38,208,719
|
|
G |
Klf10 |
Kruppel-like factor 10 |
decreases expression |
ISO |
tamibarotene results in decreased expression of KLF10 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:77,156,010...77,162,096
Ensembl chr 7:77,156,006...77,162,148
|
|
G |
Klf5 |
Kruppel-like factor 5 |
multiple interactions |
ISO |
tamibarotene inhibits the reaction [[KLF5 protein binds to [RARA protein binds to RXRA protein]] which binds to PDGFA promoter]; tamibarotene inhibits the reaction [[RARA co-treated with RXRA] promotes the reaction [KLF5 results in increased expression of PDGFA mRNA]]; tamibarotene inhibits the reaction [KLF5 protein binds to [RARA protein binds to RXRA protein]]; tamibarotene inhibits the reaction [KLF5 protein binds to PDGFA promoter]; tamibarotene inhibits the reaction [KLF5 results in increased expression of PDGFA mRNA] |
CTD |
PMID:16224062 |
|
NCBI chr15:83,703,796...83,722,921
Ensembl chr15:83,703,791...83,722,921
|
|
G |
Klf9 |
Kruppel-like factor 9 |
decreases expression |
ISO |
tamibarotene results in decreased expression of KLF9 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:240,908,483...240,933,198
Ensembl chr 1:240,908,483...240,933,198
|
|
G |
Kmt2b |
lysine methyltransferase 2B |
affects expression |
ISO |
tamibarotene affects the expression of KMT2B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:89,022,889...89,042,176
Ensembl chr 1:89,023,200...89,042,176
|
|
G |
Lamc1 |
laminin subunit gamma 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of LAMC1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr13:70,656,727...70,783,515
Ensembl chr13:70,658,707...70,783,515
|
|
G |
Lasp1 |
LIM and SH3 protein 1 |
increases expression |
ISO |
tamibarotene results in increased expression of LASP1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:85,744,662...85,785,130
Ensembl chr10:85,744,568...85,785,133
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
tamibarotene results in increased expression of LCK mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:147,750,976...147,779,627
Ensembl chr 5:147,750,973...147,761,983
|
|
G |
Lcp2 |
lymphocyte cytosolic protein 2 |
increases expression |
ISO |
tamibarotene results in increased expression of LCP2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:18,996,523...19,043,289
Ensembl chr10:18,996,523...19,043,286
|
|
G |
Lgals1 |
galectin 1 |
increases expression |
ISO |
tamibarotene results in increased expression of LGALS1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:120,153,184...120,156,290
Ensembl chr 7:120,153,184...120,156,289
|
|
G |
Lgals9 |
galectin 9 |
increases expression |
ISO |
tamibarotene results in increased expression of LGALS9 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:64,737,022...64,760,195
Ensembl chr10:64,737,022...64,760,201
|
|
G |
Lmnb1 |
lamin B1 |
affects expression |
ISO |
tamibarotene affects the expression of LMNB1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:51,785,111...51,822,264
Ensembl chr18:51,785,111...51,822,264
|
|
G |
Lpin1 |
lipin 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of LPIN1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:41,796,214...41,905,149
Ensembl chr 6:41,799,749...41,870,046
|
|
G |
Lrba |
LPS responsive beige-like anchor protein |
affects expression |
ISO |
tamibarotene affects the expression of LRBA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:185,590,983...186,110,491
Ensembl chr 2:185,524,774...186,110,495
|
|
G |
Lsm14a |
LSM14A mRNA processing body assembly factor |
decreases expression |
ISO |
tamibarotene results in decreased expression of LSM14A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:90,200,866...90,246,292
Ensembl chr 1:90,200,876...90,246,297
|
|
G |
Lsp1 |
lymphocyte-specific protein 1 |
increases expression |
ISO |
tamibarotene results in increased expression of LSP1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:215,628,750...215,662,505
Ensembl chr 1:215,628,785...215,662,504
|
|
G |
Lst1 |
leukocyte specific transcript 1 |
increases expression |
ISO |
tamibarotene results in increased expression of LST1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:5,175,213...5,179,352
Ensembl chr20:5,176,016...5,179,263
|
|
G |
Ltb4r |
leukotriene B4 receptor |
affects expression |
ISO |
tamibarotene affects the expression of LTB4R mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:34,449,299...34,453,352
Ensembl chr15:34,452,116...34,453,171
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
increases expression |
ISO |
tamibarotene results in increased expression of LY6E mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:116,355,426...116,359,862
Ensembl chr 7:116,355,698...116,359,862
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
tamibarotene results in increased expression of LYN mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:16,526,058...16,642,648
Ensembl chr 5:16,526,058...16,642,648
|
|
G |
Lztfl1 |
leucine zipper transcription factor-like 1 |
increases expression |
ISO |
tamibarotene results in increased expression of LZTFL1 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 8:132,774,393...132,790,922
Ensembl chr 8:132,775,587...132,790,839
|
|
G |
Macf1 |
microtubule-actin crosslinking factor 1 |
affects expression |
ISO |
tamibarotene affects the expression of MACF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:141,039,455...141,363,524
Ensembl chr 5:141,039,468...141,363,524
|
|
G |
Macir |
macrophage immunometabolism regulator |
decreases expression |
ISO |
tamibarotene results in decreased expression of MACIR mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:111,327,333...111,347,428
Ensembl chr 9:111,327,402...111,347,430
|
|
G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of MAP4K1 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 1:87,937,126...87,959,514
Ensembl chr 1:87,938,042...87,959,569
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO EXP |
[tamibarotene co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; tamibarotene promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] tamibarotene results in increased phosphorylation of MAPK1 protein BDNF affects the reaction [tamibarotene results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15020266 PMID:19457078 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
affects expression |
ISO |
tamibarotene affects the expression of MAPK14 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:5,933,290...5,995,137
Ensembl chr20:5,933,303...5,995,137
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO EXP |
[tamibarotene co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; tamibarotene promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] tamibarotene results in increased phosphorylation of MAPK3 protein BDNF affects the reaction [tamibarotene results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15020266 PMID:19457078 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
increases expression |
ISO |
tamibarotene results in increased expression of MAPKAPK2 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr13:47,785,157...47,871,684
Ensembl chr13:47,785,161...47,831,110
|
|
G |
Mat2a |
methionine adenosyltransferase 2A |
decreases expression |
ISO |
tamibarotene results in decreased expression of MAT2A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:100,297,478...100,303,047
Ensembl chr 4:100,296,075...100,303,080
|
|
G |
Mbp |
myelin basic protein |
multiple interactions increases expression |
EXP |
tamibarotene affects the reaction [MBP results in increased expression of IL6 mRNA]; tamibarotene inhibits the reaction [MBP results in increased expression of IFNG mRNA]; tamibarotene inhibits the reaction [MBP results in increased expression of IL10 mRNA]; tamibarotene inhibits the reaction [MBP results in increased expression of NOS2 mRNA]; tamibarotene inhibits the reaction [MBP results in increased expression of TNF mRNA] tamibarotene results in increased expression of MBP |
CTD |
PMID:11501064 PMID:19182380 |
|
NCBI chr18:79,326,738...79,437,310
Ensembl chr18:79,326,738...79,437,310
|
|
G |
Mdk |
midkine |
increases expression |
ISO |
tamibarotene results in increased expression of MDK mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916
|
|
G |
Mdm1 |
Mdm1 nuclear protein |
decreases expression |
ISO |
tamibarotene results in decreased expression of MDM1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:61,165,652...61,200,865
Ensembl chr 7:61,165,640...61,200,879
|
|
G |
Mdn1 |
midasin AAA ATPase 1 |
affects expression |
ISO |
tamibarotene affects the expression of MDN1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:47,894,526...48,036,071
Ensembl chr 5:47,894,530...48,036,287
|
|
G |
Med21 |
mediator complex subunit 21 |
affects expression |
ISO |
tamibarotene affects the expression of MED21 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:180,961,194...180,968,155
Ensembl chr 4:180,961,142...180,968,123
|
|
G |
Mfap3 |
microfibril associated protein 3 |
affects expression |
ISO |
tamibarotene affects the expression of MFAP3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:42,933,077...42,945,591
Ensembl chr10:42,933,077...42,945,564
|
|
G |
Mfge8 |
milk fat globule EGF and factor V/VIII domain containing |
increases expression |
ISO |
tamibarotene results in increased expression of MFGE8 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 1:140,845,478...140,860,882
Ensembl chr 1:140,845,465...140,860,894
|
|
G |
Morc2 |
MORC family CW-type zinc finger 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of MORC2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:83,889,138...83,930,263
Ensembl chr14:83,889,089...83,930,522
|
|
G |
Msh6 |
mutS homolog 6 |
decreases expression |
ISO |
tamibarotene results in decreased expression of MSH6 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:11,644,565...11,662,389
Ensembl chr 6:11,644,578...11,662,499
|
|
G |
Msi1 |
musashi RNA-binding protein 1 |
affects expression |
ISO |
tamibarotene affects the expression of MSI1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:46,899,835...46,935,335
Ensembl chr12:46,895,447...46,920,952
|
|
G |
Msr1 |
macrophage scavenger receptor 1 |
multiple interactions |
ISO |
tamibarotene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MSR1 mRNA] |
CTD |
PMID:16484594 |
|
NCBI chr16:56,817,714...56,900,025
Ensembl chr16:56,813,791...56,900,052
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
ISO |
tamibarotene results in increased expression of MT1A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
|
|
G |
Mt3 |
metallothionein 3 |
affects expression |
ISO |
tamibarotene affects the expression of MT3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
|
|
G |
Mta1 |
metastasis associated 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of MTA1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:137,911,302...137,950,066
Ensembl chr 6:137,924,293...137,950,075
|
|
G |
Mtg1 |
mitochondrial ribosome-associated GTPase 1 |
affects expression |
ISO |
tamibarotene affects the expression of MTG1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:212,606,753...212,619,493
Ensembl chr 1:212,606,777...212,619,493
|
|
G |
Mtmr6 |
myotubularin related protein 6 |
decreases expression |
ISO |
tamibarotene results in decreased expression of MTMR6 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:40,558,917...40,597,311
Ensembl chr15:40,558,932...40,597,309
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
affects expression |
ISO |
tamibarotene affects the expression of MYB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:16,658,178...16,690,135
Ensembl chr 1:16,659,442...16,687,817
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
tamibarotene results in decreased expression of MYC mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
increases expression |
ISO |
tamibarotene results in increased expression of MYD88 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of N4BP2L2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:627,128...650,604
Ensembl chr12:628,488...650,376
|
|
G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of NAP1L1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:54,213,305...54,237,880
Ensembl chr 7:54,213,319...54,236,625
|
|
G |
Ncbp2 |
nuclear cap binding protein subunit 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of NCBP2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:72,071,838...72,103,087
Ensembl chr11:72,921,282...72,929,003
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
increases expression |
ISO |
tamibarotene results in increased expression of NCF1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:25,497,104...25,506,300
Ensembl chr12:25,497,104...25,506,300
|
|
G |
Nck1 |
NCK adaptor protein 1 |
affects expression |
ISO |
tamibarotene affects the expression of NCK1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:108,787,797...108,847,779
Ensembl chr 8:108,787,798...108,847,779
|
|
G |
Ncoa6 |
nuclear receptor coactivator 6 |
decreases expression |
ISO |
tamibarotene results in decreased expression of NCOA6 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:150,919,317...150,990,391
Ensembl chr 3:150,919,317...150,960,030
|
|
G |
Ncor2 |
nuclear receptor co-repressor 2 |
increases expression |
ISO |
tamibarotene results in increased expression of NCOR2 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr12:36,871,917...37,033,701
Ensembl chr12:36,871,999...37,033,701
|
|
G |
Nemp1 |
nuclear envelope integral membrane protein 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of NEMP1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:70,987,860...70,996,029
Ensembl chr 7:70,987,861...70,995,474
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
increases expression |
ISO |
tamibarotene results in increased expression of NFE2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:144,872,739...144,880,092
Ensembl chr 7:144,872,747...144,880,092
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nfyb |
nuclear transcription factor Y subunit beta |
decreases expression |
ISO |
tamibarotene results in decreased expression of NFYB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 7:27,081,667...27,097,481
Ensembl chr 7:27,081,667...27,097,479
|
|
G |
Nipsnap1 |
nipsnap homolog 1 |
increases expression |
ISO |
tamibarotene results in increased expression of NIPSNAP1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:85,113,578...85,137,457
Ensembl chr14:85,113,578...85,137,454
|
|
G |
Nkg7 |
natural killer cell granule protein 7 |
increases expression |
ISO |
tamibarotene results in increased expression of NKG7 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:98,492,873...98,493,940
Ensembl chr 1:98,492,828...98,493,978
|
|
G |
Nkrf |
NFKB repressing factor |
increases expression |
ISO |
tamibarotene results in increased expression of NKRF mRNA |
CTD |
PMID:20861477 |
|
NCBI chr X:123,502,074...123,516,301
Ensembl chr X:123,502,096...123,515,720
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
tamibarotene inhibits the reaction [MBP results in increased expression of NOS2 mRNA] |
CTD |
PMID:11501064 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Npc2 |
NPC intracellular cholesterol transporter 2 |
increases expression |
ISO |
tamibarotene results in increased expression of NPC2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:108,467,410...108,488,330
Ensembl chr 6:108,467,410...108,488,330
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
increases activity multiple interactions |
ISO |
tamibarotene results in increased activity of NR1H4 protein tamibarotene inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Nr2f2 |
nuclear receptor subfamily 2, group F, member 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of NR2F2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:131,447,671...131,465,749
Ensembl chr 1:131,448,447...131,460,473
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions increases expression increases phosphorylation |
ISO EXP |
[tamibarotene co-treated with BDNF] results in increased expression of NTRK2 tamibarotene results in increased expression of NTRK2 BDNF affects the reaction [tamibarotene results in increased phosphorylation of NTRK2 protein] |
CTD |
PMID:19182380 PMID:19457078 |
|
NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
|
|
G |
Nudt21 |
nudix hydrolase 21 |
affects expression |
ISO |
tamibarotene affects the expression of NUDT21 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:11,451,366...11,470,637
Ensembl chr19:11,450,760...11,467,644
|
|
G |
Nutf2 |
nuclear transport factor 2 |
affects expression |
ISO |
tamibarotene affects the expression of NUTF2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:37,830,917...37,852,192
Ensembl chr19:37,830,917...37,852,189
|
|
G |
Oas1a |
2'-5' oligoadenylate synthetase 1A |
affects expression |
ISO |
tamibarotene affects the expression of OAS1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:41,200,680...41,211,393
Ensembl chr12:41,200,718...41,211,909
|
|
G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
increases expression |
ISO |
tamibarotene results in increased expression of OAS2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:41,341,417...41,363,124
Ensembl chr12:41,340,815...41,363,161
|
|
G |
Oasl |
2'-5'-oligoadenylate synthetase-like |
increases expression |
ISO |
tamibarotene results in increased expression of OASL mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:47,444,138...47,456,680
Ensembl chr12:47,444,104...47,456,894
|
|
G |
Ocln |
occludin |
increases expression |
ISO |
tamibarotene results in increased expression of OCLN mRNA |
CTD |
PMID:16982755 |
|
NCBI chr 2:30,527,327...30,577,218
Ensembl chr 2:30,527,715...30,577,218
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ODC1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:42,852,529...42,859,142
Ensembl chr 6:42,852,683...42,859,927
|
|
G |
Oga |
O-GlcNAcase |
decreases expression |
ISO |
tamibarotene results in decreased expression of OGA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:265,506,752...265,542,452
Ensembl chr 1:265,507,451...265,542,276
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
increases expression |
ISO |
tamibarotene results in increased expression of OGG1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
decreases expression |
ISO |
tamibarotene results in decreased expression of OGT mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:71,540,870...71,585,906
Ensembl chr X:71,528,988...71,585,908
|
|
G |
Orc2 |
origin recognition complex, subunit 2 |
decreases expression |
ISO |
tamibarotene results in decreased expression of ORC2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:65,350,630...65,387,293
Ensembl chr 9:65,350,627...65,387,169
|
|
G |
P2rx5 |
purinergic receptor P2X 5 |
increases expression |
ISO |
tamibarotene results in increased expression of P2RX5 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr10:59,725,438...59,737,126
Ensembl chr10:59,725,398...59,737,126
|
|
G |
P2ry14 |
purinergic receptor P2Y14 |
increases expression |
ISO |
tamibarotene results in increased expression of P2RY14 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:149,331,948...149,379,336
Ensembl chr 2:149,331,948...149,347,796
|
|
G |
Pak1 |
p21 (RAC1) activated kinase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of PAK1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:162,768,156...162,883,356
Ensembl chr 1:162,768,156...162,883,355
|
|
G |
Pak2 |
p21 (RAC1) activated kinase 2 |
affects expression |
ISO |
tamibarotene affects the expression of PAK2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:72,829,407...72,865,815
Ensembl chr11:72,829,238...72,865,902
|
|
G |
Pank3 |
pantothenate kinase 3 |
affects expression |
ISO |
tamibarotene affects the expression of PANK3 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr10:20,591,432...20,615,258
Ensembl chr10:20,591,432...20,615,258
|
|
G |
Papola |
poly (A) polymerase alpha |
affects expression |
ISO |
tamibarotene affects the expression of PAPOLA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:129,609,068...129,662,002
Ensembl chr 6:129,609,074...129,661,531
|
|
G |
Pcdh1 |
protocadherin 1 |
affects expression |
ISO |
tamibarotene affects the expression of PCDH1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr18:31,330,081...31,343,147
Ensembl chr18:31,328,919...31,343,797
|
|
G |
Pcmt1 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase 1 |
affects expression |
ISO |
tamibarotene affects the expression of PCMT1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:1,734,863...1,767,759
Ensembl chr 1:1,736,276...1,767,618
|
|
G |
Pcna |
proliferating cell nuclear antigen |
affects expression |
ISO |
tamibarotene affects the expression of PCNA mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pdgfa |
platelet derived growth factor subunit A |
multiple interactions |
ISO |
tamibarotene inhibits the reaction [[KLF5 protein binds to [RARA protein binds to RXRA protein]] which binds to PDGFA promoter]; tamibarotene inhibits the reaction [[RARA co-treated with RXRA] promotes the reaction [KLF5 results in increased expression of PDGFA mRNA]]; tamibarotene inhibits the reaction [KLF5 protein binds to PDGFA promoter]; tamibarotene inhibits the reaction [KLF5 results in increased expression of PDGFA mRNA]; tamibarotene inhibits the reaction [RARA protein binds to PDGFA promoter]; tamibarotene inhibits the reaction [RXRA protein binds to PDGFA promoter] |
CTD |
PMID:16224062 |
|
NCBI chr12:17,734,141...17,756,186
Ensembl chr12:17,734,133...17,755,285
|
|
G |
Pdhx |
pyruvate dehydrogenase complex, component X |
affects expression |
ISO |
tamibarotene affects the expression of PDHX mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:92,910,300...92,933,725
Ensembl chr 3:92,909,725...92,969,050
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
tamibarotene results in increased expression of PGD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:165,966,128...165,982,327
|
|
G |
Phyhip |
phytanoyl-CoA 2-hydroxylase interacting protein |
decreases expression |
ISO |
tamibarotene results in decreased expression of PHYHIP mRNA |
CTD |
PMID:15498508 |
|
NCBI chr15:52,148,737...52,160,283
Ensembl chr15:52,767,442...52,778,687
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
affects expression |
ISO |
tamibarotene affects the expression of PIK3CB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:107,275,849...107,381,088
Ensembl chr 8:107,275,725...107,380,933
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
increases expression |
ISO |
tamibarotene results in increased expression of PIK3CD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:166,602,053...166,628,028
Ensembl chr 5:166,602,053...166,628,028
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
multiple interactions increases expression |
ISO |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in increased expression of and results in increased activity of PIK3CG protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in increased expression of PIK3CG mRNA]; tamibarotene results in increased expression of and results in increased activity of PIK3CG protein |
CTD |
PMID:15020266 PMID:15498508 |
|
NCBI chr 6:51,465,696...51,501,234
Ensembl chr 6:51,465,908...51,498,337
|
|
G |
Pikfyve |
phosphoinositide kinase, FYVE-type zinc finger containing |
decreases expression |
ISO |
tamibarotene results in decreased expression of PIKFYVE mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 9:71,911,744...72,005,816
Ensembl chr 9:71,915,421...72,005,838
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
increases expression |
ISO |
tamibarotene results in increased expression of PIM1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:8,165,423...8,169,557
Ensembl chr20:8,165,307...8,169,555
|
|
G |
Pitpnb |
phosphatidylinositol transfer protein, beta |
affects expression |
ISO |
tamibarotene affects the expression of PITPNB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:51,279,194...51,341,752
Ensembl chr12:51,280,150...51,341,716
|
|
G |
Pkn1 |
protein kinase N1 |
increases expression |
ISO |
tamibarotene results in increased expression of PKN1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr19:24,803,524...24,832,305
Ensembl chr19:24,803,524...24,831,500
|
|
G |
Pkp4 |
plakophilin 4 |
decreases expression |
ISO |
tamibarotene results in decreased expression of PKP4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:45,211,097...45,414,524
Ensembl chr 3:45,277,348...45,414,613
|
|
G |
Plek |
pleckstrin |
increases expression |
ISO |
tamibarotene results in increased expression of PLEK mRNA |
CTD |
PMID:15498508 PMID:17229644 |
|
NCBI chr14:100,151,518...100,184,192
Ensembl chr14:100,151,210...100,217,913
|
|
G |
Plk4 |
polo-like kinase 4 |
decreases expression |
ISO |
tamibarotene results in decreased expression of PLK4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:127,686,911...127,705,518
Ensembl chr 2:127,686,925...127,705,518
|
|
G |
Plscr1 |
phospholipid scramblase 1 |
increases expression |
ISO |
tamibarotene results in increased expression of PLSCR1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:99,625,523...99,645,882
Ensembl chr 8:99,625,545...99,725,217
|
|
G |
Plxna1 |
plexin A1 |
increases expression |
ISO |
tamibarotene results in increased expression of PLXNA1 mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 4:121,217,658...121,262,697
Ensembl chr 4:121,217,629...121,257,885
|
|
G |
Pnn |
pinin, desmosome associated protein |
decreases expression |
ISO |
tamibarotene results in decreased expression of PNN mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:80,159,364...80,167,677
Ensembl chr 6:80,159,364...80,167,677
|
|
G |
Pold4 |
DNA polymerase delta 4, accessory subunit |
increases expression |
ISO |
tamibarotene results in increased expression of POLD4 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:219,480,841...219,483,244
Ensembl chr 1:219,481,575...219,483,241
|
|
G |
Por |
cytochrome p450 oxidoreductase |
increases expression |
ISO |
tamibarotene results in increased expression of POR mRNA |
CTD |
PMID:15498508 |
|
NCBI chr12:23,998,411...24,017,063
Ensembl chr12:23,998,411...24,046,814
|
|
G |
Ppat |
phosphoribosyl pyrophosphate amidotransferase |
decreases expression |
ISO |
tamibarotene results in decreased expression of PPAT mRNA |
CTD |
PMID:15498508 |
|
NCBI chr14:33,580,541...33,614,919
Ensembl chr14:33,580,541...33,614,919
|
|
G |
Ppfia1 |
PTPRF interacting protein alpha 1 |
decreases expression |
ISO |
tamibarotene results in decreased expression of PPFIA1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:217,644,259...217,721,285
Ensembl chr 1:217,644,224...217,721,376
|
|
G |
Ppp1cb |
protein phosphatase 1 catalytic subunit beta |
decreases expression |
ISO |
tamibarotene results in decreased expression of PPP1CB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 6:23,548,507...23,581,136
Ensembl chr 6:23,549,317...23,581,052
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
tamibarotene results in increased expression of PPP1R15A mRNA |
CTD |
PMID:17229644 |
|
NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
|
|
G |
Ppp2r1b |
protein phosphatase 2 scaffold subunit A beta |
affects expression |
ISO |
tamibarotene affects the expression of PPP2R1B mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 8:55,279,278...55,311,768
Ensembl chr 8:55,279,373...55,301,320
|
|
G |
Prdm2 |
PR/SET domain 2 |
affects expression |
ISO |
tamibarotene affects the expression of PRDM2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 5:161,769,587...161,879,150
Ensembl chr 5:161,770,653...161,879,133
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
increases expression |
ISO |
tamibarotene results in increased expression of PRKACA mRNA |
CTD |
PMID:17229644 |
|
NCBI chr19:25,095,089...25,118,869
Ensembl chr19:25,095,089...25,118,860
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
decreases expression |
ISO |
tamibarotene results in decreased expression of PRKACB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:252,602,197...252,691,886
Ensembl chr 2:252,605,307...252,691,886
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
tamibarotene results in increased expression of PRKCB mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 1:192,233,569...192,575,339
Ensembl chr 1:192,233,910...192,574,831
|
|
G |
Prkcd |
protein kinase C, delta |
increases expression |
ISO |
tamibarotene results in increased expression of PRKCD mRNA |
CTD |
PMID:15498508 |
|
NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
|
|
G |
Prkci |
protein kinase C, iota |
decreases expression |
ISO |
tamibarotene results in decreased expression of PRKCI mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 2:115,941,998...116,002,550
Ensembl chr 2:115,941,993...116,002,561
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
decreases expression affects expression |
ISO |
tamibarotene results in decreased expression of PRKDC mRNA tamibarotene affects the expression of PRKDC mRNA |
CTD |
PMID:15498508 |
|
NCBI chr11:89,293,547...89,510,948
Ensembl chr11:89,293,696...89,510,871
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
increases expression |
ISO |
tamibarotene results in increased expression of PRMT2 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr20:13,154,513...13,212,613
Ensembl chr20:13,156,241...13,212,606
|
|
G |
Prnp |
prion protein |
affects expression |
ISO |
tamibarotene affects the expression of PRNP mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:124,515,917...124,531,320
Ensembl chr 3:124,515,978...124,531,316
|
|
G |
Prpf40a |
pre-mRNA processing factor 40 homolog A |
affects expression |
ISO |
tamibarotene affects the expression of PRPF40A mRNA |
CTD |
PMID:15498508 |
|
NCBI chr 3:38,680,583...38,741,570
Ensembl chr 3:38,682,146...38,741,113
|
|
G |
Prps1 |
phosphoribosyl pyrophosphate synthetase 1 |
affects expression |
ISO |
tamibarotene affects the expression of PRPS1 mRNA |
CTD |
PMID:15498508 |
|
NCBI chr X:111,798,233...111,820,270
Ensembl chr X:111,798,233...111,820,266
|
|
G |
Prrc2c |
proline-rich coiled-coil 2C |
decreases expression |
ISO |
tamibarotene results in decreased expression of PRRC2C mRNA |
| |